M. Ahmad, S. Attoub, M. N. Singh, F. L. Martin, and O. M. El-agnaf, ?-Synuclein and the progression of cancer, FASEB J, vol.21, pp.3419-3430, 2007.

M. Al-hajj, M. S. Wicha, A. Benito-hernandez, S. J. Morrison, C. et al., , 2003.

, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci, vol.100, pp.3983-3988

O. Aprelikova, C. C. Tomlinson, M. Hoenerhoff, J. A. Hixon, S. K. Durum et al., Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases, PLoS ONE, vol.11, 2016.

S. H. Bae, W. I. Jang, and H. C. Park, Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results, Oncotarget, vol.8, pp.59965-59976, 2017.

L. Bai and L. R. Rohrschneider, s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue, Genes Dev, vol.24, pp.1882-1892, 2010.

V. Baladrón, M. J. Ruiz-hidalgo, M. L. Nueda, M. J. Díaz-guerra, J. J. García-ramírez et al., dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats, Exp. Cell Res, vol.303, pp.343-359, 2005.

S. Banerjee, J. S. Reis-filho, S. Ashley, D. Steele, A. Ashworth et al., Basal-like breast carcinomas: clinical outcome and response to chemotherapy, J. Clin. Pathol, vol.59, pp.729-735, 2006.

B. Roy, H. Vennin, C. Brocqueville, G. Spruyt, N. Adriaenssens et al., Enrichment of Human Stem-Like Prostate Cells with s-SHIP Promoter Activity Uncovers a Role in Stemness for the Long Noncoding RNA H19, Stem Cells Dev, vol.24, pp.1252-1262, 2015.

M. Bendjennat, J. Boulaire, T. Jascur, H. Brickner, V. Barbier et al., UV Irradiation Triggers Ubiquitin-Dependent Degradation of p21WAF1 to Promote DNA Repair, Cell, vol.114, pp.599-610, 2003.

D. Bonnet, D. , and J. E. , Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med, vol.3, p.730, 1997.

A. D. Borowsky, Choosing a Mouse Model: Experimental Biology in Context-The Utility and Limitations of Mouse Models of Breast Cancer, Cold Spring Harb. Perspect. Biol, 2011.

G. Brocqueville, R. S. Chmelar, H. Bauderlique-le-roy, E. Deruy, L. Tian et al., s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells, Oncotarget, vol.7, pp.29228-29244, 2016.

R. Brooks, S. Iyer, H. Akada, S. Neelam, C. M. Russo et al., Coordinate Expansion of Murine Hematopoietic and Mesenchymal Stem Cell, 2015.

S. J. Geier, P. A. Algate, K. Carlberg, D. Flowers, C. Friedman et al., The Human SHIP Gene Is Differentially Expressed in Cell Lineages of the Bone Marrow and Blood, Blood, vol.89, pp.1876-1885, 1997.

J. M. George, The synucleins, Genome Biol, vol.3, pp.3002-3003, 2002.

C. Ginestier, M. H. Hur, E. Charafe-jauffret, F. Monville, J. Dutcher et al., ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome, Cell Stem Cell, vol.1, pp.555-567, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01431968

J. Guo, C. Shou, L. Meng, B. Jiang, B. Dong et al., Neuronal protein synuclein ? predicts poor clinical outcome in breast cancer, Int. J. Cancer, vol.121, pp.1296-1305, 2007.

A. Gupta, S. Inaba, O. K. Wong, G. Fang, and J. Liu, Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1, Oncogene, vol.22, pp.7593-7599, 2003.

H. E. , K. , W. , and P. , Unregulated long non-coding RNA-AK058003 promotes the proliferation, invasion and metastasis of breast cancer by regulating the expression levels of the ?-synuclein gene, Exp. Ther. Med, vol.9, pp.1727-1732, 2015.

X. He, Y. Zheng, Y. Zhang, Y. Gan, Y. Zhou et al., Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of ?-synuclein in hepatocellular carcinoma cells, Oncotarget, vol.8, pp.9451-9465, 2016.

J. I. Herschkowitz, K. Simin, V. J. Weigman, I. Mikaelian, J. Usary et al., Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors, 2007.

, Genome Biol, vol.8, p.76

J. I. Herschkowitz, W. Zhao, M. Zhang, J. Usary, G. Murrow et al., Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells, Proc. Natl. Acad. Sci, vol.109, pp.2778-2783, 2012.

H. Hua, L. Xu, J. Wang, J. Jing, T. Luo et al., Up-regulation of gammasynuclein contributes to cancer cell survival under endoplasmic reticulum stress, J. Pathol, vol.217, pp.507-515, 2009.

A. Hunkele, H. Sultan, F. A. Ikalina, A. H. Liu, P. Nahar-gohad et al., Identification of gamma-synuclein as a new PCBP1-interacting protein, Neurol. Res, vol.38, pp.1064-1078, 2016.

Y. Huo and I. G. Macara, The Par3-like polarity protein Par3L is essential for mammary stem cell maintenance, Nat. Cell Biol, vol.16, pp.526-534, 2014.

T. Jia, Y. E. Liu, J. Liu, and Y. E. Shi, Stimulation of Breast Cancer Invasion and Metastasis by Synuclein ?, Cancer Res, vol.59, pp.742-747, 1999.

Y. Jiang, Y. E. Liu, A. Lu, A. Gupta, I. D. Goldberg et al., Stimulation of Estrogen Receptor Signaling by ? Synuclein, Cancer Res, vol.63, pp.3899-3903, 2003.

S. Kang, M. Kim, K. Song, S. Jung, J. Ahn et al., Modulation of dendritic cell function by the radiation-mediated secretory protein ?-synuclein, Cell Death Discov, vol.1, 2015.

W. M. Kavanaugh, D. A. Pot, S. M. Chin, M. Deuter-reinhard, A. B. Jefferson et al., Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2, Curr. Biol, vol.6, pp.438-445, 1996.

T. Kawakami, T. Chano, K. Minami, H. Okabe, Y. Okada et al., , 2006.

, Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma, Hum. Mol. Genet, vol.15, pp.821-830

Y. Kim, Q. Lin, D. Zelterman, Y. , and Z. , Hypoxia-Regulated Delta-like 1, 2009.

, Homologue Enhances Cancer Cell Stemness and Tumorigenicity, Cancer Res, vol.69, pp.9271-9280

N. Kogata, M. Zvelebil, H. , and B. A. , Neuregulin 3 and erbb signalling networks in embryonic mammary gland development, J. Mammary Gland Biol. Neoplasia, vol.18, pp.149-154, 2013.

M. Kralj, K. Husnjak, T. Körbler, P. , and J. , Endogenous p21 WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21 WAF1/CIP1 overexpression, Cancer Gene Ther, vol.10, p.7700588, 2003.

C. Lagadec, E. Vlashi, L. Della-donna, C. Dekmezian, P. et al., RadiationInduced Reprogramming of Breast Cancer Cells, STEM CELLS, vol.30, pp.833-844, 2012.

T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang et al., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, vol.367, p.645, 1994.

D. Lee, S. H. Yoon, H. J. Lee, K. W. Jo, B. Park et al., Human soluble delta-like 1 homolog exerts antitumor effects in vitro and in vivo, Biochem. Biophys. Res. Commun, vol.475, pp.209-215, 2016.

Y. Li, B. Welm, K. Podsypanina, S. Huang, M. Chamorro et al., Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.15853-15858, 2003.

B. Liang, X. Wang, P. Shen, X. Li, H. Cheng et al., Synuclein-? suppression mediated by RNA interference inhibits the clonogenicity and invasiveness of MCF-7 cells, Oncol. Lett, vol.5, pp.1347-1352, 2013.

B. Y. Liu, S. P. Mcdermott, S. S. Khwaja, A. , and C. M. , The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells, Proc. Natl. Acad. Sci, vol.101, pp.4158-4163, 2004.

C. Liu, B. Dong, A. Lu, L. Qu, X. Xing et al., , 2010.

, Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen, BMC Cancer, vol.10, p.359

C. Liu, B. Shi, C. Hao, Q. Wang, Q. Lv et al., Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer, Oncotarget, vol.7, pp.43432-43441, 2016.

H. Liu, W. Liu, Y. Wu, Y. Zhou, R. Xue et al., Loss of Epigenetic Control of Synuclein-? Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers, Cancer Res, vol.65, pp.7635-7643, 2005.

J. Liu, M. J. Spence, Y. L. Zhang, Y. Jiang, Y. E. Liu et al., Transcriptional suppression of synuclein ? (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M, Breast Cancer Res. Treat, vol.62, pp.99-107, 2000.

Z. Liu, G. G. Chen, E. K. Ng, W. Leung, J. J. Sung et al., , 2004.

, Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells, Oncogene, vol.23, p.1207173

Z. Ma, J. Niu, E. Sun, X. Rong, X. Zhang et al., Gamma-synuclein binds to AKT and promotes cancer cell survival and proliferation, Tumor Biol, vol.37, pp.14999-15005, 2016.

I. G. Maroulakou, M. Anver, L. Garrett, and J. E. Green, Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene, Proc. Natl. Acad. Sci. U. S. A, vol.91, pp.11236-11240, 1994.

J. P. Medema, Cancer stem cells: The challenges ahead, Nat. Cell Biol, vol.15, pp.338-344, 2013.

M. Mehta, K. Basalingappa, J. N. Griffith, D. Andrade, A. Babu et al., HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy, Oncotarget, vol.7, pp.64820-64835, 2016.

M. E. Menezes, S. K. Das, L. Emdad, J. J. Windle, X. Wang et al., Genetically Engineered Mice as Experimental Tools to Dissect the Critical Events in Breast Cancer, Adv. Cancer Res, vol.121, pp.331-382, 2014.

S. Miao, K. Wu, B. Zhang, Z. Weng, M. Zhu et al., , 2014.

, Synuclein ? Compromises Spindle Assembly Checkpoint and Renders Resistance to Antimicrotubule Drugs, Mol. Cancer Ther, vol.13, pp.699-713

L. Min, C. Zhang, R. Ma, X. Li, H. Yuan et al., Overexpression of synuclein-? predicts lack of benefit from radiotherapy for breast cancer patients, BMC Cancer, vol.16, 2016.

M. Mo, Y. Xiao, S. Huang, L. Cen, X. Chen et al., MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian, Oncotarget, vol.8, pp.15-28, 2016.

T. C. Network, Comprehensive molecular portraits of human breast tumours, Nature, vol.490, p.61, 2012.

R. M. Neve, K. Chin, J. Fridlyand, J. Yeh, F. L. Baehner et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, pp.515-527, 2006.

M. Nueda, V. Baladrón, B. Sánchez-solana, M. Ballesteros, and J. Laborda, , 2007.

, The EGF-like Protein dlk1 Inhibits Notch Signaling and Potentiates Adipogenesis of Mesenchymal Cells, J. Mol. Biol, vol.367, pp.1281-1293

M. Nueda, A. Naranjo, V. Baladrón, and J. Laborda, Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling, FASEB J, vol.31, pp.3484-3496, 2017.

S. R. Oakes, D. Gallego-ortega, and C. J. Ormandy, The mammary cellular hierarchy and breast cancer, Cell. Mol. Life Sci, vol.71, pp.4301-4324, 2014.

Z. Pan, W. Bruening, B. I. Giasson, V. M. Lee, G. et al., ?-Synuclein Promotes Cancer Cell Survival and Inhibits Stress-and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways, J. Biol. Chem, vol.277, pp.35050-35060, 2002.

A. Pannuti, K. Foreman, P. Rizzo, C. Osipo, T. Golde et al., , 2010.

, Targeting Cancer Stem Cells through Notch Signaling. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.16, pp.3141-3152

C. Peitzsch, A. Tyutyunnykova, K. Pantel, and A. Dubrovska, Cancer stem cells: The root of tumor recurrence and metastases, Semin. Cancer Biol, vol.44, pp.10-24, 2017.

A. D. Pfefferle, J. I. Herschkowitz, J. Usary, J. C. Harrell, B. T. Spike et al., Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts, 2013.

, Genome Biol, vol.14, p.125

A. Prat, B. Adamo, M. C. Cheang, C. K. Anders, L. A. Carey et al., , 2013.

, Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer, The Oncologist, vol.18, pp.123-133

T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, Stem cells, cancer, and cancer stem cells, Nature, vol.414, pp.105-111, 2001.

K. Roarty, A. N. Shore, C. J. Creighton, and J. M. Rosen, Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium, J Cell Biol, vol.208, pp.351-366, 2015.

L. R. Rohrschneider, J. M. Custodio, T. A. Anderson, C. P. Miller, and H. Gu, The intron 5/6 promoter region of the ship1 gene regulates expression in stem/progenitor cells of the mouse embryo, Dev. Biol, vol.283, pp.503-521, 2005.

K. Schaal, M. Hirschfeld, P. Bronsert, H. Füllgraf, M. Jäger et al., Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform, Oncotarget, vol.6, pp.22553-22563, 2015.

J. A. Schroeder, A. A. Masri, M. C. Adriance, J. C. Tessier, K. L. Kotlarczyk et al., MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation, Oncogene, vol.23, pp.5739-5747, 2004.

M. Shackleton, F. Vaillant, K. J. Simpson, J. Stingl, G. K. Smyth et al., Generation of a functional mammary gland from a single stem cell, Nature, vol.439, pp.84-88, 2006.

N. Shafee, C. R. Smith, S. Wei, Y. Kim, G. B. Mills et al., Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53Mediated Mouse Mammary Tumors, Cancer Res, vol.68, pp.3243-3250, 2008.

Y. Shao, B. Wang, D. Shi, S. Miao, P. Manivel et al., Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption, Mol. Oncol, vol.8, pp.1521-1531, 2014.

M. Shehata, A. Teschendorff, G. Sharp, N. Novcic, I. A. Russell et al., Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland, Breast Cancer Res, vol.14, p.134, 2012.

V. Siddartha-yerramilli and S. Scarlata, The breast cancer susceptibility gene product (?-synuclein) alters cell behavior through it interaction with phospholipase C?, Cell. Signal, vol.28, pp.91-99, 2016.

P. T. Simpson, J. S. Reis-filho, T. Gale, and S. R. Lakhani, Molecular evolution of breast cancer, J. Pathol, vol.205, pp.248-254, 2005.

V. K. Singh, Y. Zhou, J. A. Marsh, V. N. Uversky, J. D. Forman-kay et al., , 2007.

, Synuclein-? Targeting Peptide Inhibitor that Enhances Sensitivity of Breast Cancer Cells to Antimicrotubule Drugs, Cancer Res, vol.67, pp.626-633

K. E. Sleeman, H. Kendrick, A. Ashworth, C. M. Isacke, and M. J. Smalley, CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells, Breast Cancer Res, vol.8, p.7, 2005.

J. Stingl, C. , and C. , Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis, Nat. Rev. Cancer, vol.7, pp.791-799, 2007.

J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant et al., Purification and unique properties of mammary epithelial stem cells, Nature, vol.439, pp.993-997, 2006.

A. Strohl, K. Mori, S. Akers, W. Bshara, B. Buttin et al., Synuclein-? (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease, J. Ovarian Res, vol.9, p.75, 2016.

A. A. Surguchev and A. Surguchov, Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?, Front. Mol. Neurosci, vol.10, 2017.

I. Surgucheva and A. Surguchov, ?-Synuclein: Cell-Type-Specific Promoter Activity and Binding to Transcription Factors, J. Mol. Neurosci, vol.35, pp.267-271, 2008.

I. G. Surgucheva, J. M. Sivak, E. Fini, M. Palazzo, R. E. Surguchov et al., , 2003.

, Effect of ?-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells, Arch. Biochem. Biophys, vol.410, pp.167-176

N. Tanimizu, M. Nishikawa, H. Saito, T. Tsujimura, and A. Miyajima, Isolation of hepatoblasts based on the expression of Dlk/Pref-1, J. Cell Sci, vol.116, pp.1775-1786, 2003.

H. Tian, E. K. Wittmack, and T. J. Jorgensen, p21WAF1/CIP1 Antisense Therapy Radiosensitizes Human Colon Cancer by Converting Growth Arrest to Apoptosis, Cancer Res, vol.60, pp.679-684, 2000.

L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-tieulent et al., Global cancer statistics, 2012. CA, Cancer J. Clin, vol.65, pp.87-108

Z. Tu, J. M. Ninos, Z. Ma, J. Wang, M. P. Lemos et al., Embryonic and hematopoietic stem cells express a novel SH2containing inositol 5?-phosphatase isoform that partners with the Grb2 adapter protein, Blood, vol.98, pp.2028-2038, 2001.

F. Vaillant, M. Asselin-labat, M. Shackleton, N. C. Forrest, G. J. Lindeman et al., The Mammary Progenitor Marker CD61/?3 Integrin Identifies Cancer Stem Cells in Mouse Models of Mammary Tumorigenesis, Cancer Res, vol.68, pp.7711-7717, 2008.

J. E. Visvader, Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis, Genes Dev, vol.23, pp.2563-2577, 2009.

J. E. Visvader and J. Stingl, Mammary stem cells and the differentiation hierarchy: current status and perspectives, Genes Dev, vol.28, pp.1143-1158, 2014.

K. D. Voduc, M. C. Cheang, S. Tyldesley, K. Gelmon, T. O. Nielsen et al., Breast Cancer Subtypes and the Risk of Local and Regional Relapse, J. Clin. Oncol, vol.28, pp.1684-1691, 2010.

Y. Wang, X. Liu, H. Zhang, L. Sun, Y. Zhou et al., Hypoxia-Inducible lncRNA-AK058003 Promotes Gastric Cancer Metastasis by Targeting ?-Synuclein, Neoplasia, vol.16, pp.1094-1106, 2014.

R. H. Weiss, p21Waf1/Cip1 as a therapeutic target in breast and other cancers, Cancer Cell, vol.4, pp.425-429, 2003.

K. Wu, Z. Weng, Q. Tao, G. Lin, X. Wu et al., Stage-specific Expression of Breast Cancer-specific Gene ?-Synuclein, Cancer Epidemiol. Prev. Biomark, vol.12, pp.920-925, 2003.

K. Wu, Z. Quan, Z. Weng, F. Li, Y. Zhang et al., Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis, Breast Cancer Res. Treat, vol.101, pp.259-267, 2007.

H. Yanai, K. Nakamura, S. Hijioka, A. Kamei, T. Ikari et al., Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency, J. Biochem. (Tokyo), vol.148, pp.85-92, 2010.

M. Ahmad, S. Attoub, M. N. Singh, F. L. Martin, and O. M. El-agnaf, ?-Synuclein and the progression of cancer, FASEB J, vol.21, pp.3419-3430, 2007.

M. Al-hajj, M. S. Wicha, A. Benito-hernandez, S. J. Morrison, C. et al., , 2003.

, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci, vol.100, pp.3983-3988

O. Aprelikova, C. C. Tomlinson, M. Hoenerhoff, J. A. Hixon, S. K. Durum et al., Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases, PLoS ONE, vol.11, 2016.

S. H. Bae, W. I. Jang, and H. C. Park, Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results, Oncotarget, vol.8, pp.59965-59976, 2017.

L. Bai and L. R. Rohrschneider, s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue, Genes Dev, vol.24, pp.1882-1892, 2010.

V. Baladrón, M. J. Ruiz-hidalgo, M. L. Nueda, M. J. Díaz-guerra, J. J. García-ramírez et al., dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats, Exp. Cell Res, vol.303, pp.343-359, 2005.

S. Banerjee, J. S. Reis-filho, S. Ashley, D. Steele, A. Ashworth et al., Basal-like breast carcinomas: clinical outcome and response to chemotherapy, J. Clin. Pathol, vol.59, pp.729-735, 2006.

B. Roy, H. Vennin, C. Brocqueville, G. Spruyt, N. Adriaenssens et al., Enrichment of Human Stem-Like Prostate Cells with s-SHIP Promoter Activity Uncovers a Role in Stemness for the Long Noncoding RNA H19, Stem Cells Dev, vol.24, pp.1252-1262, 2015.

M. Bendjennat, J. Boulaire, T. Jascur, H. Brickner, V. Barbier et al., UV Irradiation Triggers Ubiquitin-Dependent Degradation of p21WAF1 to Promote DNA Repair, Cell, vol.114, pp.599-610, 2003.

D. Bonnet, D. , and J. E. , Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med, vol.3, p.730, 1997.

A. D. Borowsky, Choosing a Mouse Model: Experimental Biology in Context-The Utility and Limitations of Mouse Models of Breast Cancer, Cold Spring Harb. Perspect. Biol, 2011.

G. Brocqueville, R. S. Chmelar, H. Bauderlique-le-roy, E. Deruy, L. Tian et al., s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells, Oncotarget, vol.7, pp.29228-29244, 2016.

R. Brooks, S. Iyer, H. Akada, S. Neelam, C. M. Russo et al., Coordinate Expansion of Murine Hematopoietic and Mesenchymal Stem Cell Compartments by SHIPi: Chemical Expansion of HSC and Their Niche, STEM CELLS, vol.33, pp.848-858, 2015.

W. Bruening, B. I. Giasson, A. J. Klein-szanto, V. M. Lee, J. Q. Trojanowski et al., Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary, Cancer, vol.88, pp.2154-2163, 2000.

O. Cazzalini, A. I. Scovassi, M. Savio, L. A. Stivala, and E. Prosperi, Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response, Mutat. Res. Mutat. Res, vol.704, pp.12-20, 2010.

K. J. Chavez, S. V. Garimella, and S. Lipkowitz, Triple Negative Breast Cancer Cell Lines: One Tool in the Search for Better Treatment of Triple Negative Breast Cancer, Breast Dis, vol.32, pp.35-48, 2010.

J. Chen, L. Jiao, C. Xu, Y. Yu, Z. Zhang et al., Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression, BMC Cancer, vol.12, p.593, 2012.

R. W. Cho, X. Wang, M. Diehn, K. Shedden, G. Y. Chen et al., Isolation and Molecular Characterization of Cancer Stem Cells in MMTV-Wnt-1 Murine Breast Tumors, STEM CELLS, vol.26, pp.364-371, 2008.

M. F. Clarke, J. E. Dick, P. B. Dirks, C. J. Eaves, C. H. Jamieson et al., Cancer Stem Cells-Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells, Cancer Res, vol.66, pp.9339-9344, 2006.

D. F. Clayton, G. , and J. M. , The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, Trends Neurosci, vol.21, pp.249-254

C. Desponts, A. L. Hazen, K. H. Paraiso, and W. G. Kerr, SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation, Blood, vol.107, pp.4338-4345, 2006.

D. , B. Meloty-kapella, L. , W. , and G. , Canonical and noncanonical Notch ligands, Curr. Top. Dev. Biol, vol.92, pp.73-129, 2010.

K. Engelmann, H. Shen, and O. J. Finn, MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1, Cancer Res, vol.68, pp.2419-2426, 2008.

Y. Fan, A. D. Borowsky, and R. H. Weiss, An Antisense Oligodeoxynucleotide to p21Waf1/Cip1 Causes Apoptosis in Human Breast Cancer Cells1, Mol. Cancer Ther, vol.2, pp.773-782, 2003.

C. Fu, R. Lin, J. Yu, W. Chang, G. Liao et al., A Novel Oncogenic Role of Inositol Phosphatase SHIP2 in ER-Negative Breast Cancer Stem Cells: Involvement of JNK/Vimentin Activation, STEM CELLS, vol.32, pp.2048-2060, 2014.

G. Fuhler and R. Brooks, , 2012.

, Mol. Med, vol.18, p.1

S. J. Geier, P. A. Algate, K. Carlberg, D. Flowers, C. Friedman et al., The Human SHIP Gene Is Differentially Expressed in Cell Lineages of the Bone Marrow and Blood, Blood, vol.89, pp.1876-1885, 1997.

J. M. George, The synucleins, Genome Biol, vol.3, pp.3002-3003, 2002.

C. Ginestier, M. H. Hur, E. Charafe-jauffret, F. Monville, J. Dutcher et al., ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome, Cell Stem Cell, vol.1, pp.555-567, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01431968

J. Guo, C. Shou, L. Meng, B. Jiang, B. Dong et al., Neuronal protein synuclein ? predicts poor clinical outcome in breast cancer, Int. J. Cancer, vol.121, pp.1296-1305, 2007.

A. Gupta, S. Inaba, O. K. Wong, G. Fang, and J. Liu, Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1, Oncogene, vol.22, pp.7593-7599, 2003.

H. E. , K. , W. , and P. , Unregulated long non-coding RNA-AK058003 promotes the proliferation, invasion and metastasis of breast cancer by regulating the expression levels of the ?-synuclein gene, Exp. Ther. Med, vol.9, pp.1727-1732, 2015.

X. He, Y. Zheng, Y. Zhang, Y. Gan, Y. Zhou et al., Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of ?-synuclein in hepatocellular carcinoma cells, Oncotarget, vol.8, pp.9451-9465, 2016.

J. I. Herschkowitz, K. Simin, V. J. Weigman, I. Mikaelian, J. Usary et al., Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors, 2007.

, Genome Biol, vol.8, p.76

J. I. Herschkowitz, W. Zhao, M. Zhang, J. Usary, G. Murrow et al., Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells, Proc. Natl. Acad. Sci, vol.109, pp.2778-2783, 2012.

H. Hua, L. Xu, J. Wang, J. Jing, T. Luo et al., Up-regulation of gammasynuclein contributes to cancer cell survival under endoplasmic reticulum stress, J. Pathol, vol.217, pp.507-515, 2009.

A. Hunkele, H. Sultan, F. A. Ikalina, A. H. Liu, P. Nahar-gohad et al., Identification of gamma-synuclein as a new PCBP1-interacting protein, Neurol. Res, vol.38, pp.1064-1078, 2016.

Y. Huo and I. G. Macara, The Par3-like polarity protein Par3L is essential for mammary stem cell maintenance, Nat. Cell Biol, vol.16, pp.526-534, 2014.

T. Jia, Y. E. Liu, J. Liu, and Y. E. Shi, Stimulation of Breast Cancer Invasion and Metastasis by Synuclein ?, Cancer Res, vol.59, pp.742-747, 1999.

Y. Jiang, Y. E. Liu, A. Lu, A. Gupta, I. D. Goldberg et al., Stimulation of Estrogen Receptor Signaling by ? Synuclein, Cancer Res, vol.63, pp.3899-3903, 2003.

S. Kang, M. Kim, K. Song, S. Jung, J. Ahn et al., Modulation of dendritic cell function by the radiation-mediated secretory protein ?-synuclein, Cell Death Discov, vol.1, 2015.

W. M. Kavanaugh, D. A. Pot, S. M. Chin, M. Deuter-reinhard, A. B. Jefferson et al., Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2, Curr. Biol, vol.6, pp.438-445, 1996.

T. Kawakami, T. Chano, K. Minami, H. Okabe, Y. Okada et al., , 2006.

, Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma, Hum. Mol. Genet, vol.15, pp.821-830

Y. Kim, Q. Lin, D. Zelterman, Y. , and Z. , Hypoxia-Regulated Delta-like 1, 2009.
DOI : 10.1158/0008-5472.can-09-1605
URL : http://cancerres.aacrjournals.org/content/69/24/9271.full.pdf

, Homologue Enhances Cancer Cell Stemness and Tumorigenicity, Cancer Res, vol.69, pp.9271-9280

N. Kogata, M. Zvelebil, H. , and B. A. , Neuregulin 3 and erbb signalling networks in embryonic mammary gland development, J. Mammary Gland Biol. Neoplasia, vol.18, pp.149-154, 2013.

M. Kralj, K. Husnjak, T. Körbler, P. , and J. , Endogenous p21 WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21 WAF1/CIP1 overexpression, Cancer Gene Ther, vol.10, p.7700588, 2003.

C. Lagadec, E. Vlashi, L. Della-donna, C. Dekmezian, P. et al., RadiationInduced Reprogramming of Breast Cancer Cells, STEM CELLS, vol.30, pp.833-844, 2012.

T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang et al., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, vol.367, p.645, 1994.

D. Lee, S. H. Yoon, H. J. Lee, K. W. Jo, B. Park et al., Human soluble delta-like 1 homolog exerts antitumor effects in vitro and in vivo, Biochem. Biophys. Res. Commun, vol.475, pp.209-215, 2016.

Y. Li, B. Welm, K. Podsypanina, S. Huang, M. Chamorro et al., Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.15853-15858, 2003.

B. Liang, X. Wang, P. Shen, X. Li, H. Cheng et al., Synuclein-? suppression mediated by RNA interference inhibits the clonogenicity and invasiveness of MCF-7 cells, Oncol. Lett, vol.5, pp.1347-1352, 2013.

B. Y. Liu, S. P. Mcdermott, S. S. Khwaja, A. , and C. M. , The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells, Proc. Natl. Acad. Sci, vol.101, pp.4158-4163, 2004.

C. Liu, B. Dong, A. Lu, L. Qu, X. Xing et al., , 2010.

, Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen, BMC Cancer, vol.10, p.359

C. Liu, B. Shi, C. Hao, Q. Wang, Q. Lv et al., Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer, Oncotarget, vol.7, pp.43432-43441, 2016.

H. Liu, W. Liu, Y. Wu, Y. Zhou, R. Xue et al., Loss of Epigenetic Control of Synuclein-? Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers, Cancer Res, vol.65, pp.7635-7643, 2005.

J. Liu, M. J. Spence, Y. L. Zhang, Y. Jiang, Y. E. Liu et al., Transcriptional suppression of synuclein ? (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M, Breast Cancer Res. Treat, vol.62, pp.99-107, 2000.

Z. Liu, G. G. Chen, E. K. Ng, W. Leung, J. J. Sung et al., , 2004.

, Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells, Oncogene, vol.23, p.1207173

Z. Ma, J. Niu, E. Sun, X. Rong, X. Zhang et al., Gamma-synuclein binds to AKT and promotes cancer cell survival and proliferation, Tumor Biol, vol.37, pp.14999-15005, 2016.

M. Mehta, K. Basalingappa, J. N. Griffith, D. Andrade, A. Babu et al., HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy, Oncotarget, vol.7, pp.64820-64835, 2016.

M. E. Menezes, S. K. Das, L. Emdad, J. J. Windle, X. Wang et al., Genetically Engineered Mice as Experimental Tools to Dissect the Critical Events in Breast Cancer, Adv. Cancer Res, vol.121, pp.331-382, 2014.

S. Miao, K. Wu, B. Zhang, Z. Weng, M. Zhu et al., , 2014.

, Synuclein ? Compromises Spindle Assembly Checkpoint and Renders Resistance to Antimicrotubule Drugs, Mol. Cancer Ther, vol.13, pp.699-713

L. Min, C. Zhang, R. Ma, X. Li, H. Yuan et al., Overexpression of synuclein-? predicts lack of benefit from radiotherapy for breast cancer patients, BMC Cancer, vol.16, 2016.

M. Mo, Y. Xiao, S. Huang, L. Cen, X. Chen et al., MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian, Oncotarget, vol.8, pp.15-28, 2016.

T. C. Network, Comprehensive molecular portraits of human breast tumours, Nature, vol.490, p.61, 2012.

R. M. Neve, K. Chin, J. Fridlyand, J. Yeh, F. L. Baehner et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, pp.515-527, 2006.

M. Nueda, V. Baladrón, B. Sánchez-solana, M. Ballesteros, and J. Laborda, , 2007.

, The EGF-like Protein dlk1 Inhibits Notch Signaling and Potentiates Adipogenesis of Mesenchymal Cells, J. Mol. Biol, vol.367, pp.1281-1293

M. Nueda, A. Naranjo, V. Baladrón, and J. Laborda, Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling, FASEB J, vol.31, pp.3484-3496, 2017.

S. R. Oakes, D. Gallego-ortega, and C. J. Ormandy, The mammary cellular hierarchy and breast cancer, Cell. Mol. Life Sci, vol.71, pp.4301-4324, 2014.

Z. Pan, W. Bruening, B. I. Giasson, V. M. Lee, G. et al., ?-Synuclein Promotes Cancer Cell Survival and Inhibits Stress-and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways, J. Biol. Chem, vol.277, pp.35050-35060, 2002.

A. Pannuti, K. Foreman, P. Rizzo, C. Osipo, T. Golde et al., , 2010.

, Targeting Cancer Stem Cells through Notch Signaling. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.16, pp.3141-3152

C. Peitzsch, A. Tyutyunnykova, K. Pantel, and A. Dubrovska, Cancer stem cells: The root of tumor recurrence and metastases, Semin. Cancer Biol, vol.44, pp.10-24, 2017.

A. D. Pfefferle, J. I. Herschkowitz, J. Usary, J. C. Harrell, B. T. Spike et al., Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts, 2013.

, Genome Biol, vol.14, p.125

A. Prat, B. Adamo, M. C. Cheang, C. K. Anders, L. A. Carey et al., , 2013.

, Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer, The Oncologist, vol.18, pp.123-133

T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, Stem cells, cancer, and cancer stem cells, Nature, vol.414, pp.105-111, 2001.

K. Roarty, A. N. Shore, C. J. Creighton, and J. M. Rosen, Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium, J Cell Biol, vol.208, pp.351-366, 2015.

L. R. Rohrschneider, J. M. Custodio, T. A. Anderson, C. P. Miller, and H. Gu, The intron 5/6 promoter region of the ship1 gene regulates expression in stem/progenitor cells of the mouse embryo, Dev. Biol, vol.283, pp.503-521, 2005.

K. Schaal, M. Hirschfeld, P. Bronsert, H. Füllgraf, M. Jäger et al., Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform, Oncotarget, vol.6, pp.22553-22563, 2015.

J. A. Schroeder, A. A. Masri, M. C. Adriance, J. C. Tessier, K. L. Kotlarczyk et al., MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation, Oncogene, vol.23, pp.5739-5747, 2004.

M. Shackleton, F. Vaillant, K. J. Simpson, J. Stingl, G. K. Smyth et al., Generation of a functional mammary gland from a single stem cell, Nature, vol.439, pp.84-88, 2006.

N. Shafee, C. R. Smith, S. Wei, Y. Kim, G. B. Mills et al., Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53Mediated Mouse Mammary Tumors, Cancer Res, vol.68, pp.3243-3250, 2008.

Y. Shao, B. Wang, D. Shi, S. Miao, P. Manivel et al., Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption, Mol. Oncol, vol.8, pp.1521-1531, 2014.

M. Shehata, A. Teschendorff, G. Sharp, N. Novcic, I. A. Russell et al., Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland, Breast Cancer Res, vol.14, p.134, 2012.

V. Siddartha-yerramilli and S. Scarlata, The breast cancer susceptibility gene product (?-synuclein) alters cell behavior through it interaction with phospholipase C?, Cell. Signal, vol.28, pp.91-99, 2016.

P. T. Simpson, J. S. Reis-filho, T. Gale, and S. R. Lakhani, Molecular evolution of breast cancer, J. Pathol, vol.205, pp.248-254, 2005.

V. K. Singh, Y. Zhou, J. A. Marsh, V. N. Uversky, J. D. Forman-kay et al., , 2007.

, Synuclein-? Targeting Peptide Inhibitor that Enhances Sensitivity of Breast Cancer Cells to Antimicrotubule Drugs, Cancer Res, vol.67, pp.626-633

K. E. Sleeman, H. Kendrick, A. Ashworth, C. M. Isacke, and M. J. Smalley, CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells, Breast Cancer Res, vol.8, p.7, 2005.

J. Stingl, C. , and C. , Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis, Nat. Rev. Cancer, vol.7, pp.791-799, 2007.

J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant et al., Purification and unique properties of mammary epithelial stem cells, Nature, vol.439, pp.993-997, 2006.

A. Strohl, K. Mori, S. Akers, W. Bshara, B. Buttin et al., Synuclein-? (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease, J. Ovarian Res, vol.9, p.75, 2016.

A. A. Surguchev and A. Surguchov, Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?, Front. Mol. Neurosci, vol.10, 2017.

I. Surgucheva and A. Surguchov, ?-Synuclein: Cell-Type-Specific Promoter Activity and Binding to Transcription Factors, J. Mol. Neurosci, vol.35, pp.267-271, 2008.

I. G. Surgucheva, J. M. Sivak, E. Fini, M. Palazzo, R. E. Surguchov et al., , 2003.

, Effect of ?-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells, Arch. Biochem. Biophys, vol.410, pp.167-176

N. Tanimizu, M. Nishikawa, H. Saito, T. Tsujimura, and A. Miyajima, Isolation of hepatoblasts based on the expression of Dlk/Pref-1, J. Cell Sci, vol.116, pp.1775-1786, 2003.

H. Tian, E. K. Wittmack, and T. J. Jorgensen, p21WAF1/CIP1 Antisense Therapy Radiosensitizes Human Colon Cancer by Converting Growth Arrest to Apoptosis, Cancer Res, vol.60, pp.679-684, 2000.

L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-tieulent et al., Global cancer statistics, 2012. CA, Cancer J. Clin, vol.65, pp.87-108
DOI : 10.3322/caac.21262
URL : https://onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21262

Z. Tu, J. M. Ninos, Z. Ma, J. Wang, M. P. Lemos et al., Embryonic and hematopoietic stem cells express a novel SH2containing inositol 5?-phosphatase isoform that partners with the Grb2 adapter protein, Blood, vol.98, pp.2028-2038, 2001.

F. Vaillant, M. Asselin-labat, M. Shackleton, N. C. Forrest, G. J. Lindeman et al., The Mammary Progenitor Marker CD61/?3 Integrin Identifies Cancer Stem Cells in Mouse Models of Mammary Tumorigenesis, Cancer Res, vol.68, pp.7711-7717, 2008.

J. E. Visvader, Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis, Genes Dev, vol.23, pp.2563-2577, 2009.

J. E. Visvader and J. Stingl, Mammary stem cells and the differentiation hierarchy: current status and perspectives, Genes Dev, vol.28, pp.1143-1158, 2014.

K. D. Voduc, M. C. Cheang, S. Tyldesley, K. Gelmon, T. O. Nielsen et al., Breast Cancer Subtypes and the Risk of Local and Regional Relapse, J. Clin. Oncol, vol.28, pp.1684-1691, 2010.

Y. Wang, X. Liu, H. Zhang, L. Sun, Y. Zhou et al., Hypoxia-Inducible lncRNA-AK058003 Promotes Gastric Cancer Metastasis by Targeting ?-Synuclein, Neoplasia, vol.16, pp.1094-1106, 2014.

R. H. Weiss, p21Waf1/Cip1 as a therapeutic target in breast and other cancers, Cancer Cell, vol.4, pp.425-429, 2003.

K. Wu, Z. Weng, Q. Tao, G. Lin, X. Wu et al., Stage-specific Expression of Breast Cancer-specific Gene ?-Synuclein, Cancer Epidemiol. Prev. Biomark, vol.12, pp.920-925, 2003.

K. Wu, Z. Quan, Z. Weng, F. Li, Y. Zhang et al., Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis, Breast Cancer Res. Treat, vol.101, pp.259-267, 2007.

H. Yanai, K. Nakamura, S. Hijioka, A. Kamei, T. Ikari et al., Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency, J. Biochem. (Tokyo), vol.148, pp.85-92, 2010.

H. Zhang, A. Kouadio, D. Cartledge, G. , and A. K. , Role of Gamma-synuclein in Microtubule Regulation, Exp. Cell Res, vol.317, pp.1330-1339, 2011.

M. Zhang, F. Behbod, R. L. Atkinson, M. D. Landis, F. Kittrell et al., Identification of Tumor-initiating Cells in a p53 Null Mouse Model of Breast Cancer, Cancer Res, vol.68, pp.4674-4682, 2008.

Y. Zhou, S. Inaba, and J. Liu, Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials, Int. J. Oncol, vol.29, pp.1757-1770, 2000.

E. V. Abel, E. J. Kim, J. Wu, M. Hynes, F. Bednar et al., The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer, PloS One, vol.9, 2014.

S. Adams, J. R. Diamond, E. P. Hamilton, P. R. Pohlmann, S. M. Tolaney et al., Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC), J. Clin. Oncol, vol.34, pp.1009-1009, 2016.

G. Afshar, N. Jelluma, X. Yang, D. Basila, N. D. Arvold et al., Radiation-induced caspase-8 mediates p53independent apoptosis in glioma cells, Cancer Res, vol.66, pp.4223-4232, 2006.

A. Aghajanyan and I. Suskov, Transgenerational genomic instability in children of irradiated parents as a result of the Chernobyl Nuclear Accident, Mutat. Res, vol.671, pp.52-57, 2009.

M. Ahmad, S. Attoub, M. N. Singh, F. L. Martin, and O. M. El-agnaf, ?-Synuclein and the progression of cancer, FASEB J, vol.21, pp.3419-3430, 2007.

D. Ahuja, M. T. Sáenz-robles, and J. M. Pipas, SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation, Oncogene, vol.24, pp.7729-7745, 2005.

L. E. Ailles and I. L. Weissman, Cancer stem cells in solid tumors, Curr. Opin. Biotechnol, vol.18, pp.460-466, 2007.

M. Al-hajj, M. S. Wicha, A. Benito-hernandez, S. J. Morrison, C. et al., , 2003.

, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci, vol.100, pp.3983-3988

J. M. Allan, T. , and L. B. , Mechanisms of therapy-related carcinogenesis, Nat. Rev. Cancer, vol.5, pp.943-955, 2005.

E. J. Allenspach, I. Maillard, J. C. Aster, and W. S. Pear, Notch signaling in cancer, Cancer Biol. Ther, vol.1, pp.466-476, 2002.

R. Van-amerongen, A. N. Bowman, N. , and R. , Developmental stage and time dictate the fate of Wnt/?-catenin-responsive stem cells in the mammary gland, Cell Stem Cell, vol.11, pp.387-400, 2012.

O. Aprelikova, C. C. Tomlinson, M. Hoenerhoff, J. A. Hixon, S. K. Durum et al., Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases, PLoS ONE, vol.11, 2016.

S. Artavanis-tsakonas, M. D. Rand, and R. J. Lake, Notch signaling: cell fate control and signal integration in development, Science, vol.284, pp.770-776, 1999.

I. A. Asangani, S. Rasheed, .. K. Nikolova, D. A. Leupold, J. H. Colburn et al., MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer, Oncogene, vol.27, pp.2128-2136, 2008.

M. Asselin-labat, K. D. Sutherland, H. Barker, R. Thomas, M. Shackleton et al., Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation, Nat. Cell Biol, vol.9, pp.201-209, 2007.

E. I. Azzam, S. M. De-toledo, and J. B. Little, Stress signaling from irradiated to nonirradiated cells, Curr. Cancer Drug Targets, vol.4, pp.53-64, 2004.

E. I. Azzam, J. Jay-gerin, and D. Pain, Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury, Cancer Lett, vol.327, pp.48-60, 2012.

L. Bai and L. R. Rohrschneider, s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue, Genes Dev, vol.24, pp.1882-1892, 2010.

V. Baladrón, M. J. Ruiz-hidalgo, M. L. Nueda, M. J. Díaz-guerra, J. J. García-ramírez et al., dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats, Exp. Cell Res, vol.303, pp.343-359, 2005.

S. Bao, Q. Wu, R. E. Mclendon, Y. Hao, Q. Shi et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, vol.444, pp.756-760, 2006.

R. C. Barber, P. Hickenbotham, T. Hatch, D. Kelly, N. Topchiy et al., Radiation-induced transgenerational alterations in genome stability and DNA damage, Oncogene, vol.25, pp.7336-7342, 2006.

H. Bartelink, J. Horiot, P. Poortmans, H. Struikmans, W. Van-den-bogaert et al., Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation, N. Engl. J. Med, vol.345, pp.1378-1387, 2001.

C. Basse, A. , and M. , The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment, Int. J. Cancer, vol.137, pp.2785-2794, 2015.

E. Batlle, C. , and H. , Cancer stem cells revisited, Nat. Med, vol.23, pp.1124-1134, 2017.

B. Roy, H. Vennin, C. Brocqueville, G. Spruyt, N. Adriaenssens et al., Enrichment of Human Stem-Like Prostate Cells with s-SHIP Promoter Activity Uncovers a Role in Stemness for the Long Noncoding RNA H19, Stem Cells Dev, vol.24, pp.1252-1262, 2015.

C. M. Baum, I. L. Weissman, A. S. Tsukamoto, A. M. Buckle, P. et al., Isolation of a candidate human hematopoietic stem-cell population, Proc. Natl. Acad. Sci. U. S. A, vol.89, pp.2804-2808, 1992.

F. F. Beça, . De, P. Caetano, R. Gerhard, C. A. Alvarenga et al., Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types, J. Clin. Pathol, vol.66, pp.187-191, 2013.

A. Begum, Y. Kim, Q. Lin, Y. , and Z. , DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo, Cancer Lett, vol.318, pp.26-33, 2012.

C. Belka, P. Marini, W. Budach, K. Schulze-osthoff, F. Lang et al., Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand, Radiat. Res, vol.149, pp.588-595, 1998.

G. Bertolini, L. Roz, P. Perego, M. Tortoreto, E. Fontanella et al., Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.16281-16286, 2009.

J. A. Bertout, A. J. Majmundar, J. D. Gordan, J. C. Lam, D. Ditsworth et al., HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.14391-14396, 2009.

E. Birben, U. M. Sahiner, C. Sackesen, S. Erzurum, and O. Kalayci, Oxidative Stress and Antioxidant Defense, World Allergy Organ. J, vol.5, p.9, 2012.

R. Bjerkvig, B. B. Tysnes, K. S. Aboody, J. Najbauer, and A. J. Terzis, Opinion: the origin of the cancer stem cell: current controversies and new insights, Nat. Rev. Cancer, vol.5, pp.899-904, 2005.

A. Bleau, D. Hambardzumyan, T. Ozawa, E. I. Fomchenko, J. T. Huse et al., PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells, Cell Stem Cell, vol.4, pp.226-235, 2009.

D. Bonnet, D. , and J. E. , Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med, vol.3, p.730, 1997.

A. Bonnomet, L. Syne, A. Brysse, E. Feyereisen, E. W. Thompson et al., A dynamic in vivo model of epithelial-tomesenchymal transitions in circulating tumor cells and metastases of breast cancer, Oncogene, vol.31, pp.3741-3753, 2012.

T. Brabletz, A. Jung, S. Spaderna, F. Hlubek, and T. Kirchner, Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression, Nat. Rev. Cancer, vol.5, pp.744-749, 2005.

J. Briscoe and P. P. Thérond, The mechanisms of Hedgehog signalling and its roles in development and disease, Nat. Rev. Mol. Cell Biol, vol.14, pp.416-429, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00831295

G. Brocqueville, R. S. Chmelar, H. Bauderlique-le-roy, E. Deruy, L. Tian et al., s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells, Oncotarget, vol.7, pp.29228-29244, 2016.

R. Brooks, S. Iyer, H. Akada, S. Neelam, C. M. Russo et al., Coordinate Expansion of Murine Hematopoietic and Mesenchymal Stem Cell Compartments by SHIPi: Chemical Expansion of HSC and Their Niche, STEM CELLS, vol.33, pp.848-858, 2015.

V. L. Buchman, H. J. Hunter, L. G. Pinõn, J. Thompson, E. M. Privalova et al., Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system, J. Neurosci. Off. J. Soc. Neurosci, vol.18, pp.9335-9341, 1998.

U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan et al., A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells, EMBO Rep, vol.9, pp.582-589, 2008.

S. Byler, S. Goldgar, S. Heerboth, M. Leary, G. Housman et al., Genetic and epigenetic aspects of breast cancer progression and therapy, Anticancer Res, vol.34, pp.1071-1077, 2014.

S. M. Cabarcas, L. A. Mathews, and W. L. Farrar, The cancer stem cell niche-there goes the neighborhood?, Int. J. Cancer, vol.129, pp.2315-2327, 2011.

J. Campisi and F. Adda-di-fagagna, Cellular senescence: when bad things happen to good cells, Nat. Rev. Mol. Cell Biol, vol.8, pp.729-740, 2007.

M. Cariati, A. Naderi, J. P. Brown, M. J. Smalley, S. E. Pinder et al., Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line, Int. J. Cancer, vol.122, pp.298-304, 2008.

A. Casazza, G. Di-conza, M. Wenes, V. Finisguerra, S. Deschoemaeker et al., Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment, Oncogene, vol.33, pp.1743-1754, 2014.

T. Celià-terrassa, O. Meca-cortés, F. Mateo, A. Martínez-de-paz, N. Rubio et al., Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells, J. Clin. Invest, vol.122, pp.1849-1868, 2012.

C. L. Chaffer, I. Brueckmann, C. Scheel, A. J. Kaestli, P. A. Wiggins et al., Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.7950-7955, 2011.

T. Chanmee, P. Ontong, K. Konno, and N. Itano, Tumor-associated macrophages as major players in the tumor microenvironment, Cancers, vol.6, pp.1670-1690, 2014.

E. Charafe-jauffret, C. Ginestier, F. Iovino, J. Wicinski, N. Cervera et al., Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature, Cancer Res, vol.69, pp.1302-1313, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01431954

E. Charafe-jauffret, C. Ginestier, F. Bertucci, O. Cabaud, J. Wicinski et al., ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program, Cancer Res, vol.73, pp.7290-7300, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01431937

P. Chaturvedi, D. M. Gilkes, C. C. Wong, . Kshitiz, W. Luo et al., Hypoxia-inducible factor-dependent breast cancermesenchymal stem cell bidirectional signaling promotes metastasis, J. Clin. Invest, vol.123, pp.189-205, 2013.

N. Chen, K. , and V. , Role and regulation of autophagy in cancer, Biochim. Biophys. Acta, vol.1793, pp.1516-1523, 2009.

B. Chen, M. E. Dodge, W. Tang, J. Lu, Z. Ma et al., Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer, Nat. Chem. Biol, vol.5, pp.100-107, 2009.

J. Chen, P. Ding, L. Li, H. Gu, X. Zhang et al., CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance, Stem Cell Rep, vol.8, pp.140-151, 2016.

K. Chen, Y. Huang, C. , and J. , Understanding and targeting cancer stem cells: therapeutic implications and challenges, Acta Pharmacol. Sin, vol.34, pp.732-740, 2013.

A. M. Cheung, T. S. Wan, J. C. Leung, L. Y. Chan, H. Huang et al., Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential, Leukemia, vol.21, pp.1423-1430, 2007.

N. Chikazawa, H. Tanaka, T. Tasaka, M. Nakamura, M. Tanaka et al., Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells, Anticancer Res, vol.30, pp.2041-2048, 2010.

R. W. Cho, X. Wang, M. Diehn, K. Shedden, G. Y. Chen et al., Isolation and Molecular Characterization of Cancer Stem Cells in MMTV-Wnt-1 Murine Breast Tumors, STEM CELLS, vol.26, pp.364-371, 2008.

M. F. Clarke and M. Fuller, Stem cells and cancer: two faces of eve, Cell, vol.124, pp.1111-1115, 2006.

M. F. Clarke, J. E. Dick, P. B. Dirks, C. J. Eaves, C. H. Jamieson et al., Cancer Stem Cells-Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells, Cancer Res, vol.66, pp.9339-9344, 2006.

V. Clement, P. Sanchez, N. De-tribolet, I. Radovanovic, and A. Ruiz-i-altaba, , 2007.

, HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity, Curr. Biol. CB, vol.17, pp.165-172

H. Clevers, Wnt/beta-catenin signaling in development and disease, Cell, vol.127, pp.469-480, 2006.

H. Clevers, The cancer stem cell: premises, promises and challenges, Nat. Med, vol.17, pp.313-319, 2011.

A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland, Prospective Identification of Tumorigenic Prostate Cancer Stem Cells, Cancer Res, vol.65, pp.10946-10951, 2005.

P. P. Connell and S. Hellman, Advances in radiotherapy and implications for the next century: a historical perspective, Cancer Res, vol.69, pp.383-392, 2009.

R. M. Connolly, N. K. Nguyen, and S. Sukumar, Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.19, pp.1651-1659, 2013.

S. Corti, F. Locatelli, D. Papadimitriou, C. Donadoni, S. Salani et al., Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity, Stem Cells Dayt. Ohio, vol.24, pp.975-985, 2006.

G. Cotsarelis, T. T. Sun, and R. M. Lavker, Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis, Cell, vol.61, pp.1329-1337, 1990.

P. Cottu, E. Marangoni, F. Assayag, P. De-cremoux, A. Vincent-salomon et al.,

L. Plater, C. Elbaz, N. Karboul, and J. J. Fontaine, Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts, Breast Cancer Res. Treat, vol.133, pp.595-606, 2012.

A. Cozzio, E. Passegué, P. M. Ayton, H. Karsunky, M. L. Cleary et al., , 2003.

, Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors, Genes Dev, vol.17, pp.3029-3035

C. J. Creighton, X. Li, M. Landis, J. M. Dixon, V. M. Neumeister et al., Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features, Proc. Natl. Acad. Sci, vol.106, pp.13820-13825, 2009.

A. K. Croker, A. , and A. L. , Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44 + human breast cancer cells, Breast Cancer Res. Treat, vol.133, pp.75-87, 2012.

A. K. Croker, D. Goodale, J. Chu, C. Postenka, B. D. Hedley et al., High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability, J. Cell. Mol. Med, vol.13, pp.2236-2252, 2009.

S. W. Crowder, D. A. Balikov, Y. Hwang, and H. Sung, Cancer Stem Cells under Hypoxia as a Chemoresistance Factor in Breast and Brain, Curr. Pathobiol. Rep, vol.2, pp.33-40, 2014.

B. G. Cuiffo and A. E. Karnoub, Mesenchymal stem cells in tumor development: emerging roles and concepts, Cell Adhes. Migr, vol.6, pp.220-230, 2012.

P. Dalerba, R. W. Cho, C. , and M. F. , Cancer stem cells: models and concepts, Annu. Rev. Med, vol.58, pp.267-284, 2007.

B. Dave, V. Mittal, N. M. Tan, C. , and J. C. , Epithelial-mesenchymal transition, cancer stem cells and treatment resistance, Breast Cancer Res. BCR, vol.14, p.202, 2012.

M. Dean, T. Fojo, and S. Bates, Tumour stem cells and drug resistance, Nat. Rev. Cancer, vol.5, pp.275-284, 2005.

K. Debatin and P. H. Krammer, Death receptors in chemotherapy and cancer, Oncogene, vol.23, pp.2950-2966, 2004.

Y. S. Derose, G. Wang, Y. Lin, P. S. Bernard, S. S. Buys et al., Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes, Nat. Med, vol.17, pp.1514-1520, 2011.

O. Desouky, N. Ding, and G. Zhou, Targeted and non-targeted effects of ionizing radiation, J. Radiat. Res. Appl. Sci, vol.8, pp.247-254, 2015.

C. Desponts, J. M. Ninos, and W. G. Kerr, s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival, Stem Cells Dev, vol.15, pp.641-646, 2006.

J. E. Dick, Stem cell concepts renew cancer research, Blood, vol.112, pp.4793-4807, 2008.

M. Diehn, R. W. Cho, N. A. Lobo, T. Kalisky, M. J. Dorie et al., Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature, vol.458, pp.780-783, 2009.

L. E. Dobrolecki, S. D. Airhart, D. G. Alferez, S. Aparicio, F. Behbod et al., Patient-derived xenograft (PDX) models in basic and translational breast cancer research, Cancer Metastasis Rev, vol.35, pp.547-573, 2016.

C. Dong, T. Yuan, Y. Wu, Y. Wang, T. W. Fan et al., Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer, Cancer Cell, vol.23, pp.316-331, 2013.

G. Dontu, M. Al-hajj, W. M. Abdallah, M. F. Clarke, and M. S. Wicha, Stem cells in normal breast development and breast cancer, Cell Prolif, vol.36, issue.1, pp.59-72, 2003.

G. Dontu, W. M. Abdallah, J. M. Foley, K. W. Jackson, M. F. Clarke et al., In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes Dev, vol.17, pp.1253-1270, 2003.

G. Dontu, K. W. Jackson, E. Mcnicholas, M. J. Kawamura, W. M. Abdallah et al., Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells, Breast Cancer Res. BCR, vol.6, pp.605-615, 2004.

M. K. Dougherty, L. M. Schumaker, V. C. Jordan, W. V. Welshons, E. M. Curran et al., Estrogen receptor expression and sensitivity to paclitaxel in breast cancer, Cancer Biol. Ther, vol.3, pp.460-467, 2004.

M. Dowsett, J. Cuzick, J. Ingle, A. Coates, J. Forbes et al., Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.28, pp.509-518, 2010.

J. M. Drake, G. Strohbehn, T. B. Bair, J. G. Moreland, and M. D. Henry, ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells, Mol. Biol. Cell, vol.20, pp.2207-2217, 2009.

D. , B. Meloty-kapella, L. , W. , and G. , Canonical and noncanonical Notch ligands, Curr. Top. Dev. Biol, vol.92, pp.73-129, 2010.

Y. E. Dubrova, Radiation-induced transgenerational instability, Oncogene, vol.22, pp.7087-7093, 2003.

D. Duffell, R. Hinz, N. , and E. , Neoplasms in Hamsters Induced by Simian Virus 40, Am. J. Pathol, vol.45, pp.59-73, 1964.

C. Dumontet, J. , and M. A. , Microtubule-binding agents: a dynamic field of cancer therapeutics, Nat. Rev. Drug Discov, vol.9, pp.790-803, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00526519

M. Durante and J. S. Loeffler, Charged particles in radiation oncology, Nat. Rev. Clin. Oncol, vol.7, pp.37-43, 2010.

P. Eirew, J. Stingl, A. Raouf, G. Turashvili, S. Aparicio et al., A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability, Nat. Med, vol.14, pp.1384-1389, 2008.

P. Eirew, N. Kannan, D. J. Knapp, F. Vaillant, J. T. Emerman et al., Aldehyde dehydrogenase activity is a biomarker of primitive normal human mammary luminal cells, Stem Cells Dayt. Ohio, vol.30, pp.344-348, 2012.

R. El-helou, G. Pinna, O. Cabaud, J. Wicinski, R. Bhajun et al., miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling, Cell Rep, vol.18, pp.2256-2268, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01789620

S. Elmore, Apoptosis: a review of programmed cell death, Toxicol. Pathol, vol.35, pp.495-516, 2007.

J. Erenpreisa, M. Kalejs, and M. S. Cragg, Mitotic catastrophe and endomitosis in tumour cells: an evolutionary key to a molecular solution, Cell Biol. Int, vol.29, pp.1012-1018, 2005.

D. Eriksson and T. Stigbrand, Radiation-induced cell death mechanisms, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med, vol.31, pp.363-372, 2010.

J. H. Van-es, M. E. Van-gijn, O. Riccio, M. Van-den-born, M. Vooijs et al., Notch/?-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells, Nature, vol.435, pp.959-963, 2005.

A. Esquela-kerscher and F. J. Slack, Oncomirs-microRNAs with a role in cancer, Nat. Rev. Cancer, vol.6, pp.259-269, 2006.

F. Essmann, I. H. Engels, G. Totzke, K. Schulze-osthoff, J. et al., Apoptosis Resistance of MCF-7 Breast Carcinoma Cells to Ionizing Radiation Is Independent of p53 and Cell Cycle Control but Caused by the Lack of Caspase-3 and a Caffeine-Inhibitable Event, Cancer Res, vol.64, pp.7065-7072, 2004.

F. A. Falix, D. C. Aronson, W. H. Lamers, and I. C. Gaemers, Possible roles of DLK1 in the Notch pathway during development and disease, Biochim. Biophys. Acta BBA-Mol. Basis Dis, vol.1822, pp.988-995, 2012.

D. Fang, T. K. Nguyen, K. Leishear, R. Finko, A. N. Kulp et al., A tumorigenic subpopulation with stem cell properties in melanomas, Cancer Res, vol.65, pp.9328-9337, 2005.

M. M. Faraldo, J. Teulière, M. Deugnier, I. T. Hosseraye, J. P. Thiery et al., Myoepithelial Cells in the Control of Mammary Development and Tumorigenesis: Data From Genetically Modified Mice, J. Mammary Gland Biol. Neoplasia, vol.10, pp.211-219, 2005.

M. K. Farrugia, S. B. Sharma, C. Lin, S. L. Mclaughlin, D. B. Vanderbilt et al., Regulation of antiapoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer, Cell Death Dis, vol.6, p.1699, 2015.

F. Ferraro, C. L. Celso, and D. Scadden, ADULT STEM CELLS AND THEIR NICHES, Adv. Exp. Med. Biol, vol.695, pp.155-168, 2010.

C. M. Fillmore and C. Kuperwasser, Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy, Breast Cancer Res, vol.10, p.25, 2008.

J. M. Fleming, T. C. Miller, M. J. Meyer, E. Ginsburg, and B. K. Vonderhaar, Local regulation of human breast xenograft models, J. Cell. Physiol, vol.224, pp.795-806, 2010.

A. Fourquet, S. Krhili, F. Campana, A. Chilles, and Y. Kirova, , 2016.

C. Fu, R. Lin, J. Yu, W. Chang, G. Liao et al., A Novel Oncogenic Role of Inositol Phosphatase SHIP2 in ER-Negative Breast Cancer Stem Cells: Involvement of JNK/Vimentin Activation, STEM CELLS, vol.32, pp.2048-2060, 2014.

G. Fuhler and R. Brooks, , 2012.

, Mol. Med, vol.18, p.1

A. S. Fung, C. Lee, M. Yu, and I. F. Tannock, The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts, BMC Cancer, vol.15, p.112, 2015.

R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti et al., Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma, Cancer Res, vol.64, pp.7011-7021, 2004.

J. E. Galvin, V. M. Lee, and J. Q. Trojanowski, Synucleinopathies: clinical and pathological implications, Arch. Neurol, vol.58, pp.186-190, 2001.

L. Gammon, A. Biddle, H. K. Heywood, A. C. Johannessen, M. et al., Subsets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism, PloS One, vol.8, 2013.

M. Gao, Y. Choi, S. Kang, J. H. Youn, and N. Cho, CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells, Oncogene, vol.29, pp.2672-2680, 2010.

J. M. George, The synucleins, Genome Biol, vol.3, pp.3002-3003, 2002.

D. A. Gewirtz, S. E. Holt, E. , and L. W. , Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation, Biochem. Pharmacol, vol.76, pp.947-957, 2008.

L. Ghisolfi, A. C. Keates, X. Hu, D. Lee, L. et al., Ionizing radiation induces stemness in cancer cells, PloS One, vol.7, p.43628, 2012.

C. Ginestier, M. H. Hur, E. Charafe-jauffret, F. Monville, J. Dutcher et al., ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome, Cell Stem Cell, vol.1, pp.555-567, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01431968

C. Ginestier, F. Monville, J. Wicinski, O. Cabaud, N. Cervera et al., Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target, Stem Cells Dayt. Ohio, vol.30, pp.1327-1337, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01431941

A. Golebiewska, N. H. Brons, R. Bjerkvig, and S. P. Niclou, Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research, Cell Stem Cell, vol.8, pp.136-147, 2011.

C. Gong, Y. Yao, Y. Wang, B. Liu, W. Wu et al., , 2011.

, Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer, J. Biol. Chem, vol.286, pp.19127-19137

M. A. Goodell, K. Brose, G. Paradis, A. S. Conner, and R. C. Mulligan, Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, J. Exp. Med, vol.183, pp.1797-1806, 1996.

J. E. Green, M. A. Shibata, K. Yoshidome, M. L. Liu, C. Jorcyk et al., The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma, Oncogene, vol.19, pp.1020-1027, 2000.

A. Gupta, S. Inaba, O. K. Wong, G. Fang, and J. Liu, Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1, Oncogene, vol.22, pp.7593-7599, 2003.

H. Hahn, C. Wicking, P. G. Zaphiropoulous, M. R. Gailani, S. Shanley et al., Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome, Cell, vol.85, pp.841-851, 1996.

R. Hamam, D. Hamam, K. A. Alsaleh, M. Kassem, W. Zaher et al., Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers, Cell Death Dis, vol.8, p.3045, 2017.

D. Hanahan and L. M. Coussens, Accessories to the crime: functions of cells recruited to the tumor microenvironment, Cancer Cell, vol.21, pp.309-322, 2012.

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, pp.646-674, 2011.

A. Haque, N. L. Banik, R. , and S. K. , Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma, Neurochem. Res, vol.32, pp.2203-2209, 2007.

S. Haupt, M. Berger, Z. Goldberg, and Y. Haupt, Apoptosis-the p53 network, J. Cell Sci, vol.116, pp.4077-4085, 2003.

J. M. Heddleston, Z. Li, R. E. Mclendon, A. B. Hjelmeland, R. et al., The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle Georget. Tex, vol.8, pp.3274-3284, 2009.

K. Helczynska, A. Kronblad, A. Jögi, E. Nilsson, S. Beckman et al., Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ, Cancer Res, vol.63, pp.1441-1444, 2003.

J. R. Hens and J. J. Wysolmerski, Key stages of mammary gland development: molecular mechanisms involved in the formation of the embryonic mammary gland, Breast Cancer Res. BCR, vol.7, pp.220-224, 2005.

P. C. Hermann, S. L. Huber, T. Herrler, A. Aicher, J. W. Ellwart et al., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, vol.1, pp.313-323, 2007.

J. I. Herschkowitz, K. Simin, V. J. Weigman, I. Mikaelian, J. Usary et al., Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors, 2007.

, Genome Biol, vol.8, p.76

J. I. Herschkowitz, W. Zhao, M. Zhang, J. Usary, G. Murrow et al., Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells, Proc. Natl. Acad. Sci, vol.109, pp.2778-2783, 2012.

D. A. Hess, T. E. Meyerrose, L. Wirthlin, T. P. Craft, P. E. Herrbrich et al., Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity, Blood, vol.104, pp.1648-1655, 2004.

M. Hiraki, T. Maeda, A. Bouillez, M. Alam, A. Tagde et al., MUC1-C activates BMI1 in human cancer cells, Oncogene, vol.36, pp.2791-2801, 2017.

Y. Hirose, M. Katayama, O. K. Mirzoeva, M. S. Berger, and R. O. Pieper, Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence, Cancer Res, vol.65, pp.4861-4869, 2005.

I. Holen, V. Speirs, B. Morrissey, and K. Blyth, In vivo models in breast cancer research: progress, challenges and future directions, Dis. Model. Mech, vol.10, pp.359-371, 2017.

G. Honeth, P. Bendahl, M. Ringnér, L. H. Saal, S. K. Gruvberger-saal et al., The CD44+/CD24-phenotype is enriched in basal-like breast tumors, Breast Cancer Res, vol.10, 2008.

S. B. Horwitz, Taxol (paclitaxel): mechanisms of action, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.5, issue.6, pp.3-6, 1994.

J. Houghton, W. D. George, J. Cuzick, C. Duggan, I. S. Fentiman et al., UK Coordinating Committee on Cancer Research, Ductal Carcinoma in situ Working Party, and DCIS trialists in the UK, Lancet Lond. Engl, vol.362, pp.95-102, 2003.

T. Hu, R. Zhou, Y. Zhao, and G. Wu, Integrin ?6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy, Sci. Rep, vol.6, p.33376, 2016.

W. Hu, X. Ge, T. You, T. Xu, J. Zhang et al., Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis, Cancer Res, vol.71, pp.2298-2307, 2011.

C. Huang, C. C. Park, S. G. Hilsenbeck, R. Ward, M. F. Rimawi et al., ?1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib, Breast Cancer Res. BCR, vol.13, p.84, 2011.

E. H. Huang, M. J. Hynes, T. Zhang, C. Ginestier, G. Dontu et al., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis, Cancer Res, vol.69, pp.3382-3389, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01431953

H. Huang, S. Chin, C. Ginestier, V. Bardou, J. Adélaïde et al., A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene, Cancer Res, vol.64, pp.6840-6844, 2004.

T. Huang, A. Alvarez, B. Hu, and S. Cheng, Noncoding RNAs in cancer and cancer stem cells, Chin. J. Cancer, vol.32, pp.582-593, 2013.

Z. Huang, M. Epperly, S. C. Watkins, J. S. Greenberger, V. E. Kagan et al., , 2016.

, Necrostatin-1 rescues mice from lethal irradiation, Biochim. Biophys. Acta BBA-Mol. Basis Dis, vol.1862, pp.850-856

B. J. Huntly, H. Shigematsu, K. Deguchi, B. H. Lee, S. Mizuno et al., MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors, Cancer Cell, vol.6, pp.587-596, 2004.

Y. Huo and I. G. Macara, The Par3-like polarity protein Par3L is essential for mammary stem cell maintenance, Nat. Cell Biol, vol.16, pp.526-534, 2014.

Y. Hüsemann, J. B. Geigl, F. Schubert, P. Musiani, M. Meyer et al., Systemic spread is an early step in breast cancer, Cancer Cell, vol.13, pp.58-68, 2008.

W. W. Hwang-verslues, W. Kuo, P. Chang, C. Pan, H. Wang et al., Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers, PloS One, vol.4, p.8377, 2009.

F. Ianzini, A. Bertoldo, E. A. Kosmacek, S. L. Phillips, and M. A. Mackey, Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells, Cancer Cell Int, vol.6, p.11, 2006.

S. Inaba, C. Li, Y. E. Shi, D. Song, J. Jiang et al., Synuclein Gamma Inhibits the Mitotic Checkpoint Function and Promotes Chromosomal Instability of Breast Cancer Cells, Breast Cancer Res. Treat, vol.94, pp.25-35, 2005.

A. Incassati, A. Chandramouli, R. Eelkema, C. , and P. , Key signaling nodes in mammary gland development and cancer: ?-catenin, Breast Cancer Res. BCR, vol.12, p.213, 2010.

J. L. Inman, C. Robertson, J. D. Mott, and M. J. Bissell, Mammary gland development: cell fate specification, stem cells and the microenvironment, Development, vol.142, pp.1028-1042, 2015.

M. V. Iorio, M. Ferracin, C. Liu, A. Veronese, R. Spizzo et al., MicroRNA gene expression deregulation in human breast cancer, Cancer Res, vol.65, pp.7065-7070, 2005.

H. Ito, S. Daido, T. Kanzawa, S. Kondo, and Y. Kondo, Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells, Int. J. Oncol, vol.26, pp.1401-1410, 2005.

S. P. Jackson and J. Bartek, The DNA-damage response in human biology and disease, Nature, vol.461, pp.1071-1078, 2009.

G. Jang, J. Kim, S. Cho, K. Park, J. Jung et al., Blockade of Wnt/?-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype, Sci. Rep, vol.5, p.12465, 2015.

K. B. Jensen and F. M. Watt, Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.11958-11963, 2006.

H. Ji, Y. E. Liu, T. Jia, M. Wang, J. Liu et al., Identification of a Breast Cancer-specific Gene, BCSG1, by Direct Differential cDNA Sequencing, Cancer Res, vol.57, pp.759-764, 1997.

H. Jia, C. I. Truica, B. Wang, Y. Wang, X. Ren et al., Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects, Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother, vol.32, pp.1-15, 2017.

T. Jia, Y. E. Liu, J. Liu, and Y. E. Shi, Stimulation of Breast Cancer Invasion and Metastasis by Synuclein ?, Cancer Res, vol.59, pp.742-747, 1999.

L. Jiang, J. Li, and L. Song, Bmi-1, stem cells and cancer, Acta Biochim. Biophys. Sin, vol.41, pp.527-534, 2009.

Y. Jiang, Y. E. Liu, A. Lu, A. Gupta, I. D. Goldberg et al., Stimulation of Estrogen Receptor Signaling by ? Synuclein, Cancer Res, vol.63, pp.3899-3903, 2003.

T. Kadesch, Notch Signaling: A Dance of Proteins Changing Partners, Exp. Cell Res, vol.260, pp.1-8, 2000.

M. A. Kadhim, D. A. Macdonald, D. T. Goodhead, S. A. Lorimore, S. J. Marsden et al., Transmission of chromosomal instability after plutonium alpha-particle irradiation, Nature, vol.355, pp.738-740, 1992.

J. H. Kang, S. Krause, H. Tobin, A. Mammoto, M. Kanapathipillai et al., , 2012.

, A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells, Lab. Chip, vol.12, pp.2175-2181

J. Kao, K. Salari, M. Bocanegra, Y. Choi, L. Girard et al., Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery, PloS One, vol.4, p.6146, 2009.

F. Karimi-busheri, A. Rasouli-nia, J. R. Mackey, W. , and M. , Senescence evasion by MCF-7 human breast tumor-initiating cells, Breast Cancer Res. BCR, vol.12, p.31, 2010.

R. E. Kast, Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma, Cancer Biol. Ther, vol.7, pp.1515-1519, 2008.

W. M. Kavanaugh, D. A. Pot, S. M. Chin, M. Deuter-reinhard, A. B. Jefferson et al., Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2, Curr. Biol, vol.6, pp.438-445, 1996.

B. Keith and M. C. Simon, Hypoxia-Inducible Factors, vol.129, pp.465-472, 2007.

P. J. Keller, L. M. Arendt, A. Skibinski, T. Logvinenko, I. Klebba et al., Defining the cellular precursors to human breast cancer, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.2772-2777, 2012.

P. N. Kelly, A. Dakic, J. M. Adams, S. L. Nutt, and A. Strasser, Tumor growth need not be driven by rare cancer stem cells, Science, vol.317, p.337, 2007.

W. G. Kerr, A role for SHIP in stem cell biology and transplantation, Curr. Stem Cell Res. Ther, vol.3, pp.99-106, 2008.

J. F. Kerr, A. H. Wyllie, and A. R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer, vol.26, pp.239-257, 1972.

C. F. Kim, E. L. Jackson, A. E. Woolfenden, S. Lawrence, I. Babar et al., Identification of bronchioalveolar stem cells in normal lung and lung cancer, Cell, vol.121, pp.823-835, 2005.

Y. Kim, Q. Lin, D. Zelterman, Y. , and Z. , Hypoxia-Regulated Delta-like 1, 2009.

, Homologue Enhances Cancer Cell Stemness and Tumorigenicity, Cancer Res, vol.69, pp.9271-9280

T. Kitamura, B. Qian, and J. W. Pollard, Immune cell promotion of metastasis, Nat. Rev. Immunol, vol.15, pp.73-86, 2015.

S. Kleffel and T. Schatton, Tumor dormancy and cancer stem cells: two sides of the same coin?, Adv. Exp. Med. Biol, vol.734, pp.145-179, 2013.

N. Kogata, M. Zvelebil, H. , and B. A. , Neuregulin 3 and erbb signalling networks in embryonic mammary gland development, J. Mammary Gland Biol. Neoplasia, vol.18, pp.149-154, 2013.

A. Kreso, C. A. O'brien, P. Van-galen, O. I. Gan, F. Notta et al., Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer, Science, vol.339, pp.543-548, 2013.

G. Kroemer, J. Perfettini, K. Andreau, M. Castedo, R. Medema et al., Cell death by mitotic catastrophe: a molecular definition, Oncogene, vol.23, p.2825, 2004.

T. Kuilman and D. S. Peeper, Senescence-messaging secretome: SMS-ing cellular stress, Nat. Rev. Cancer, vol.9, pp.81-94, 2009.

T. Kume, Novel insights into the differential functions of Notch ligands in vascular formation, J. Angiogenesis Res, 2009.

C. Kuperwasser, T. Chavarria, M. Wu, G. Magrane, J. W. Gray et al., Reconstruction of functionally normal and malignant human breast tissues in mice, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.4966-4971, 2004.

N. K. Kurrey, S. P. Jalgaonkar, A. V. Joglekar, A. D. Ghanate, P. D. Chaskar et al., Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells, Stem Cells Dayt. Ohio, vol.27, pp.2059-2068, 2009.

C. Lagadec, E. Vlashi, L. Della-donna, C. Dekmezian, P. et al., RadiationInduced Reprogramming of Breast Cancer Cells, STEM CELLS, vol.30, pp.833-844, 2012.

K. Lauber, A. Ernst, M. Orth, M. Herrmann, and C. Belka, Dying cell clearance and its impact on the outcome of tumor radiotherapy, Front. Oncol, vol.2, 2012.

C. Lavedan, E. Leroy, A. Dehejia, S. Buchholtz, A. Dutra et al., Identification, localization and characterization of the human gamma-synuclein gene, Hum. Genet, vol.103, pp.106-112, 1998.

E. Y. Lee and W. J. Muller, Oncogenes and Tumor Suppressor Genes, Cold Spring Harb. Perspect. Biol, vol.2, 2010.

K. B. Leszczynska, I. P. Foskolou, A. G. Abraham, S. Anbalagan, C. Tellier et al., Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT, vol.125, pp.2385-2398, 2015.

A. J. Levine, p53, the cellular gatekeeper for growth and division, Cell, vol.88, pp.323-331, 1997.

N. C. Levitt and I. D. Hickson, Caretaker tumour suppressor genes that defend genome integrity, Trends Mol. Med, vol.8, pp.179-186, 2002.

Z. Li, R. , and J. N. , Hypoxia and hypoxia inducible factors in cancer stem cell maintenance, Curr. Top. Microbiol. Immunol, vol.345, pp.21-30, 2010.

H. Li, L. Zhu, L. Xu, K. Qin, C. Liu et al., Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer, Mol. Carcinog, vol.56, pp.3-17, 2017.

H. Li, F. Reinhardt, H. R. Herschman, and R. A. Weinberg, Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling, Cancer Discov, vol.2, pp.840-855, 2012.

P. Li, C. Zhou, L. Xu, X. , and H. , Hypoxia enhances stemness of cancer stem cells in glioblastoma: an in vitro study, Int. J. Med. Sci, vol.10, pp.399-407, 2013.

X. Li, M. T. Lewis, J. Huang, C. Gutierrez, C. K. Osborne et al., Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy, J. Natl. Cancer Inst, vol.100, pp.672-679, 2008.

Z. Li, G. M. Sclabas, B. Peng, K. R. Hess, J. L. Abbruzzese et al., Overexpression of synuclein-gamma in pancreatic adenocarcinoma, Cancer, vol.101, pp.58-65, 2004.

Z. Li, S. Bao, Q. Wu, H. Wang, C. Eyler et al., Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells, Cancer Cell, vol.15, pp.501-513, 2009.

W. Liang, S. Miao, B. Zhang, S. He, C. Shou et al., Synuclein ? protects Akt and mTOR and renders tumor resistance to Hsp90 disruption, Oncogene, vol.34, p.2014126, 2014.

E. Lim, F. Vaillant, D. Wu, N. C. Forrest, B. Pal et al., Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers, Nat. Med, vol.15, pp.907-913, 2009.

H. Lin, The stem-cell niche theory: lessons from flies, Nat. Rev. Genet, vol.3, pp.931-940, 2002.

C. Lindvall, N. C. Evans, C. R. Zylstra, Y. Li, C. M. Alexander et al., , 2006.

, The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1induced tumorigenesis, J. Biol. Chem, vol.281, pp.35081-35087

J. B. Little, Cellular radiation effects and the bystander response, Mutat. Res. Mol. Mech. Mutagen, vol.597, pp.113-118, 2006.

C. Liu, L. Qu, S. Lian, Z. Tian, C. Zhao et al., Unconventional secretion of synuclein-? promotes tumor cell invasion, FEBS J, vol.281, pp.5159-5171, 2014.

H. Liu, W. Liu, Y. Wu, Y. Zhou, R. Xue et al., Loss of Epigenetic Control of Synuclein-? Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers, Cancer Res, vol.65, pp.7635-7643, 2005.

J. Liu, M. J. Spence, Y. L. Zhang, Y. Jiang, Y. E. Liu et al., Transcriptional suppression of synuclein ? (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M, Breast Cancer Res. Treat, vol.62, pp.99-107, 2000.

J. Liu, S. Pan, M. H. Hsieh, N. Ng, F. Sun et al., Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974, Proc. Natl. Acad. Sci. U. S. A, vol.110, pp.20224-20229, 2013.

M. L. Liu, F. C. Von-lintig, M. Liyanage, M. A. Shibata, C. L. Jorcyk et al., Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice, Oncogene, vol.17, pp.2403-2411, 1998.

M. L. Liu, M. A. Shibata, F. C. Von-lintig, W. Wang, S. Cassenaer et al., Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice, Oncogene, vol.20, pp.2044-2049, 2001.

S. Liu, G. Dontu, I. D. Mantle, S. Patel, N. Ahn et al., Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells, Cancer Res, vol.66, pp.6063-6071, 2006.

S. Liu, C. Ginestier, S. J. Ou, S. G. Clouthier, S. H. Patel et al., Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, Cancer Res, vol.71, pp.614-624, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01431944

S. Liu, Y. Cong, D. Wang, Y. Sun, L. Deng et al., Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts, Stem Cell Rep, vol.2, pp.78-91, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01431931

B. Lloyd-lewis, O. B. Harris, C. J. Watson, D. , and F. M. , Mammary Stem Cells: Premise, Properties, and Perspectives, Trends Cell Biol, vol.27, pp.556-567, 2017.

A. Loaiza-bonilla, S. D. Gore, and H. E. Carraway, Novel approaches for myelodysplastic syndromes: beyond hypomethylating agents, Curr. Opin. Hematol, vol.17, pp.104-109, 2010.

H. Löffler, J. Lukas, J. Bartek, and A. Krämer, Structure meets function-centrosomes, genome maintenance and the DNA damage response, Exp. Cell Res, vol.312, pp.2633-2640, 2006.

S. A. Lorimore, M. A. Kadhim, D. A. Pocock, D. Papworth, D. L. Stevens et al., Chromosomal instability in the descendants of unirradiated surviving cells after alpha-particle irradiation, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.5730-5733, 1998.

E. Louie, S. Nik, J. Chen, M. Schmidt, B. Song et al., Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation, Breast Cancer Res. BCR, vol.12, p.94, 2010.

J. Lu, X. Ye, F. Fan, L. Xia, R. Bhattacharya et al., Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1, Cancer Cell, vol.23, pp.171-185, 2013.

P. Lu, V. M. Weaver, and Z. Werb, The extracellular matrix: a dynamic niche in cancer progression, J. Cell Biol, vol.196, pp.395-406, 2012.

N. M. Van-der-lugt, J. Domen, K. Linders, M. Van-roon, E. Robanus-maandag et al., Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene, Genes Dev, vol.8, pp.757-769, 1994.

M. B. Lustberg and B. Ramaswamy, Epigenetic Therapy in Breast Cancer, Curr. Breast Cancer Rep, vol.3, pp.34-43, 2011.

S. Ma, T. K. Lee, B. Zheng, K. W. Chan, and X. Guan, CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway, Oncogene, vol.27, pp.1749-1758, 2008.

X. Ma, D. Holt, N. Kundu, J. Reader, O. Goloubeva et al., A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2mediated immunosuppression and inhibits breast cancer metastasis, vol.2, p.22647, 2013.

B. T. Macdonald, K. Tamai, and X. He, Wnt/beta-catenin signaling: components, mechanisms, and diseases, Dev. Cell, vol.17, pp.9-26, 2009.

P. Macor, E. Secco, N. Mezzaroba, S. Zorzet, P. Durigutto et al., Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice, Leukemia, vol.29, pp.406-414, 2015.

Z. Madjd, A. Z. Mehrjerdi, A. M. Sharifi, S. Molanaei, S. Z. Shahzadi et al., CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours, Cancer Immun, vol.9, p.4, 2009.

S. A. Mani, W. Guo, M. Liao, E. N. Eaton, A. Ayyanan et al., The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, vol.133, pp.704-715, 2008.

N. D. Marjanovic, R. A. Weinberg, and C. L. Chaffer, Cell plasticity and heterogeneity in cancer, Clin. Chem, vol.59, pp.168-179, 2013.

I. G. Maroulakou, M. Anver, L. Garrett, and J. E. Green, Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene, Proc. Natl. Acad. Sci. U. S. A, vol.91, pp.11236-11240, 1994.

W. H. Matsui, Cancer stem cell signaling pathways, Medicine (Baltimore), vol.95, pp.8-19, 2016.

S. Mattiske, R. J. Suetani, P. M. Neilsen, and D. F. Callen, The oncogenic role of miR155 in breast cancer, Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol, vol.21, pp.1236-1243, 2012.

B. T. Mcgrogan, B. Gilmartin, D. N. Carney, and A. Mccann, Taxanes, microtubules and chemoresistant breast cancer, Biochim. Biophys. Acta, vol.1785, pp.96-132, 2008.

D. Medina, Of Mice and Women: A Short History of Mouse Mammary Cancer Research with an Emphasis on the Paradigms Inspired by the Transplantation Method, Cold Spring Harb. Perspect. Biol, vol.2, 2010.

D. Medina, F. S. Kittrell, A. Shepard, L. C. Stephens, C. Jiang et al., Biological and genetic properties of the p53 null preneoplastic mammary epithelium, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.16, pp.881-883, 2002.

L. Melchor and J. Benítez, An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes, Carcinogenesis, vol.29, pp.1475-1482, 2008.

M. E. Menezes, S. K. Das, L. Emdad, J. J. Windle, X. Wang et al., Genetically Engineered Mice as Experimental Tools to Dissect the Critical Events in Breast Cancer, Adv. Cancer Res, vol.121, pp.331-382, 2014.

A. A. Merchant and W. Matsui, Targeting Hedgehog-a cancer stem cell pathway, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.16, pp.3130-3140, 2010.

K. R. Mesa, P. Rompolas, and V. Greco, The Dynamic Duo: Niche/Stem Cell Interdependency, Stem Cell Rep, vol.4, pp.961-966, 2015.

L. Min, C. Zhang, R. Ma, X. Li, H. Yuan et al., Overexpression of synuclein-? predicts lack of benefit from radiotherapy for breast cancer patients, BMC Cancer, vol.16, 2016.

R. Mirzayans, B. Andrais, A. Scott, Y. W. Wang, M. et al., Ionizing radiationinduced responses in human cells with differing TP53 status, Int. J. Mol. Sci, vol.14, pp.22409-22435, 2013.

A. V. Molofsky, S. He, M. Bydon, S. J. Morrison, P. et al., Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways, Genes Dev, vol.19, pp.1432-1437, 2005.

G. Molyneux, F. C. Geyer, F. Magnay, A. Mccarthy, H. Kendrick et al., BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells, Cell Stem Cell, vol.7, pp.403-417, 2010.

A. Morel, M. Lièvre, C. Thomas, G. Hinkal, S. Ansieau et al., Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition, PLoS ONE, vol.3, 2008.

W. F. Morgan and M. B. Sowa, Effects of ionizing radiation in nonirradiated cells, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.14127-14128, 2005.

S. J. Morrison and J. Kimble, Asymmetric and symmetric stem-cell divisions in development and cancer, Nature, vol.441, pp.1068-1074, 2006.

S. J. Morrison and I. L. Weissman, The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype, Immunity, vol.1, pp.661-673, 1994.

H. Nagasawa and J. B. Little, Induction of sister chromatid exchanges by extremely low doses of alpha-particles, Cancer Res, vol.52, pp.6394-6396, 1992.

P. Nagy, A. J. Kettle, and C. C. Winterbourn, Superoxide-mediated Formation of Tyrosine Hydroperoxides and Methionine Sulfoxide in Peptides through Radical Addition and Intramolecular Oxygen Transfer, J. Biol. Chem, vol.284, pp.14723-14733, 2009.

C. Nardella, J. G. Clohessy, A. Alimonti, and P. P. Pandolfi, Pro-senescence therapy for cancer treatment, Nat. Rev. Cancer, vol.11, pp.503-511, 2011.

S. Nath and P. Mukherjee, MUC1: a multifaceted oncoprotein with a key role in cancer progression, Trends Mol. Med, vol.20, pp.332-342, 2014.

A. Nebbioso, V. Carafa, R. Benedetti, A. , and L. , Trials with "epigenetic" drugs: an update, Mol. Oncol, vol.6, pp.657-682, 2012.

M. A. Nehs, C. Lin, D. E. Kozono, E. E. Whang, N. L. Cho et al., Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers, Surgery, vol.150, pp.1032-1039, 2011.

T. C. Network, Comprehensive molecular portraits of human breast tumours, Nature, vol.490, p.61, 2012.

R. M. Neve, K. Chin, J. Fridlyand, J. Yeh, F. L. Baehner et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, pp.515-527, 2006.

M. Nicolas, A. Wolfer, K. Raj, J. A. Kummer, P. Mill et al., Notch1 functions as a tumor suppressor in mouse skin, Nat. Genet, vol.33, pp.416-421, 2003.

M. A. Nieto, The ins and outs of the epithelial to mesenchymal transition in health and disease, Annu. Rev. Cell Dev. Biol, vol.27, pp.347-376, 2011.

N. N. Ninkina, M. V. Alimova-kost, J. W. Paterson, L. Delaney, B. B. Cohen et al., Organization, expression and polymorphism of the human persyn gene, Hum. Mol. Genet, vol.7, pp.1417-1424, 1998.

F. Notta, C. G. Mullighan, J. C. Wang, A. Poeppl, S. Doulatov et al., Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells, Nature, vol.469, pp.362-367, 2011.

P. C. Nowell, The Clonal Evolution of Tumor Cell Populations, Science, vol.194, pp.23-28, 1976.

M. Nueda, V. Baladrón, B. Sánchez-solana, M. Ballesteros, and J. Laborda, , 2007.

, The EGF-like Protein dlk1 Inhibits Notch Signaling and Potentiates Adipogenesis of Mesenchymal Cells, J. Mol. Biol, vol.367, pp.1281-1293

M. Nueda, A. Naranjo, V. Baladrón, and J. Laborda, Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling, FASEB J, vol.31, pp.3484-3496, 2017.

O. H. Ocaña, R. Córcoles, A. Fabra, G. Moreno-bueno, H. Acloque et al., Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1, Cancer Cell, vol.22, pp.709-724, 2012.

A. Ogura, S. Oowada, Y. Kon, A. Hirayama, H. Yasui et al., Redox regulation in radiation-induced cytochrome c release from mitochondria of human lung carcinoma A549 cells, Cancer Lett, vol.277, pp.64-71, 2009.

Y. Ohi, Y. Umekita, T. Yoshioka, M. Souda, Y. Rai et al., Aldehyde dehydrogenase 1 expression predicts poor prognosis in triplenegative breast cancer, Histopathology, vol.59, pp.776-780, 2011.

M. Osawa, K. Hanada, H. Hamada, and H. Nakauchi, Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell, Science, vol.273, pp.242-245, 1996.

C. Osborne, P. Wilson, and D. Tripathy, Oncogenes and Tumor Suppressor Genes in Breast Cancer: Potential Diagnostic and Therapeutic Applications, The Oncologist, vol.9, pp.361-377, 2004.

I. Ota, X. Li, Y. Hu, and S. J. Weiss, Induction of a MT1-MMP and MT2-MMPdependent basement membrane transmigration program in cancer cells by Snail1, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.20318-20323, 2009.

S. Paglin, T. Hollister, T. Delohery, N. Hackett, M. Mcmahill et al., A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles, Cancer Res, vol.61, pp.439-444, 2001.

I. S. Paine, L. , and M. T. , The Terminal End Bud: the Little Engine that Could, J. Mammary Gland Biol. Neoplasia, vol.22, pp.93-108, 2017.

Z. Pan, W. Bruening, B. I. Giasson, V. M. Lee, G. et al., ?-Synuclein Promotes Cancer Cell Survival and Inhibits Stress-and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways, J. Biol. Chem, vol.277, pp.35050-35060, 2002.

T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik, MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells, Cancer Res, vol.68, pp.8164-8172, 2008.

A. N. Paranjape, S. A. Balaji, T. Mandal, E. V. Krushik, P. Nagaraj et al., Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog, BMC Cancer, vol.14, p.785, 2014.

I. Park, D. Qian, M. Kiel, M. W. Becker, M. Pihalja et al., Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells, Nature, vol.423, pp.302-305, 2003.

J. Park, M. G. Rasch, J. Qiu, I. K. Lund, E. et al., Presence of Insulin-Like Growth Factor Binding Proteins Correlates With Tumor-Promoting Effects of Matrix Metalloproteinase 9 in Breast Cancer, Neoplasia, vol.17, pp.421-433, 2015.

S. Y. Park, H. E. Lee, H. Li, M. Shipitsin, R. Gelman et al., Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.16, pp.876-887, 2010.

D. Pasquali, V. Rossi, G. Bellastella, A. Bellastella, and A. A. Sinisi, Natural and synthetic retinoids in prostate cancer, Curr. Pharm. Des, vol.12, pp.1923-1929, 2006.

E. Pastrana, V. Silva-vargas, and F. Doetsch, Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells, Cell Stem Cell, vol.8, pp.486-498, 2011.

L. Patrawala, T. Calhoun, R. Schneider-broussard, J. Zhou, K. Claypool et al., Side Population Is Enriched in Tumorigenic, Stem-Like Cancer Cells, whereas ABCG2 + and ABCG2 ? Cancer Cells Are Similarly Tumorigenic, Cancer Res, vol.65, pp.6207-6219, 2005.

D. R. Pattabiraman and R. A. Weinberg, Tackling the cancer stem cells-what challenges do they pose?, Nat. Rev. Drug Discov, vol.13, pp.497-512, 2014.

A. D. Paula and C. Lopes, Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer, Anticancer Res, vol.37, pp.2173-2183, 2017.

C. D. Peacock, Q. Wang, G. S. Gesell, I. M. Corcoran-schwartz, E. Jones et al., Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.4048-4053, 2007.

S. Pece, D. Tosoni, S. Confalonieri, G. Mazzarol, M. Vecchi et al., Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content, Cell, vol.140, pp.62-73, 2010.

C. Peitzsch, A. Tyutyunnykova, K. Pantel, and A. Dubrovska, Cancer stem cells: The root of tumor recurrence and metastases, Semin. Cancer Biol, vol.44, pp.10-24, 2017.

R. P. Perez, T. C. Hamilton, R. F. Ozols, Y. , and R. C. , Mechanisms and modulation of resistance to chemotherapy in ovarian cancer, Cancer, vol.71, pp.1571-1580, 1993.

C. M. Perou, Molecular stratification of triple-negative breast cancers, The Oncologist, vol.16, pp.61-70, 2011.

C. M. Perou, T. Sørlie, M. B. Eisen, M. Rijn, J. Van-de et al., Molecular portraits of human breast tumours, Nature, vol.406, p.747, 2000.

X. Pesesse, S. Deleu, F. De-smedt, L. Drayer, and C. Erneux, Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP, Biochem. Biophys. Res. Commun, vol.239, pp.697-700, 1997.

A. D. Pfefferle, J. I. Herschkowitz, J. Usary, J. C. Harrell, B. T. Spike et al., Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts, 2013.

, Genome Biol, vol.14, p.125

T. M. Phillips, W. H. Mcbride, P. , and F. , The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation, J. Natl. Cancer Inst, vol.98, pp.1777-1785, 2006.

M. T. Piccolo, C. , and S. , The Dual Role Played by p21 May Influence the Apoptotic or Anti-Apoptotic Fate in Cancer, J. Cancer Res. Updat, vol.1, pp.189-202, 2012.

D. Pinto, A. Gregorieff, H. Begthel, C. , and H. , Canonical Wnt signals are essential for homeostasis of the intestinal epithelium, Genes Dev, vol.17, pp.1709-1713, 2003.

V. Plaks, N. Kong, and Z. Werb, The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?, Cell Stem Cell, vol.16, pp.225-238, 2015.

K. Polyak, Breast cancer: origins and evolution, J. Clin. Invest, vol.117, pp.3155-3163, 2007.

D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini et al., Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties, Cancer Res, vol.65, pp.5506-5511, 2005.

C. P. Ponting, P. L. Oliver, R. , and W. , Evolution and functions of long noncoding RNAs, Cell, vol.136, pp.629-641, 2009.

A. Prat, J. S. Parker, O. Karginova, C. Fan, C. Livasy et al., Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Res, vol.12, p.68, 2010.

T. A. Proia, P. J. Keller, P. B. Gupta, I. Klebba, A. D. Jones et al., Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate, 2011.

E. Quintana, M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson et al., Efficient tumour formation by single human melanoma cells, Nature, vol.456, pp.593-598, 2008.

D. C. Radisky, Y. Hirai, and M. J. Bissell, Delivering the message: epimorphin and mammary epithelial morphogenesis, Trends Cell Biol, vol.13, pp.426-434, 2003.

G. Rainaldi, A. Ferrante, P. L. Indovina, and M. T. Santini, Induction of apoptosis or necrosis by ionizing radiation is dose-dependent in MG-63 osteosarcoma multicellular spheroids, Anticancer Res, vol.23, pp.2505-2518, 2003.

E. A. Rakha, J. S. Reis-filho, E. , and I. O. , Basal-Like Breast Cancer: A Critical Review, J. Clin. Oncol, vol.26, pp.2568-2581, 2008.

M. Rebucci and C. Michiels, Molecular aspects of cancer cell resistance to chemotherapy, Biochem. Pharmacol, vol.85, pp.1219-1226, 2013.

T. Reya, C. , and H. , Wnt signalling in stem cells and cancer, Nature, vol.434, pp.843-850, 2005.

T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, Stem cells, cancer, and cancer stem cells, Nature, vol.414, pp.105-111, 2001.

T. Reya, A. W. Duncan, L. Ailles, J. Domen, D. C. Scherer et al., A role for Wnt signalling in self-renewal of haematopoietic stem cells, Nature, vol.423, pp.409-414, 2003.

A. D. Rhim, E. T. Mirek, N. M. Aiello, A. Maitra, J. M. Bailey et al., EMT and dissemination precede pancreatic tumor formation, Cell, vol.148, pp.349-361, 2012.

S. Ricardo, A. F. Vieira, R. Gerhard, D. Leitão, R. Pinto et al., Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype, J. Clin. Pathol, vol.64, pp.937-946, 2011.

M. M. Richert, K. L. Schwertfeger, J. W. Ryder, A. , and S. M. , An Atlas of Mouse Mammary Gland Development, J. Mammary Gland Biol. Neoplasia, vol.5, pp.227-241, 2000.

A. C. Rios, N. Y. Fu, G. J. Lindeman, and J. E. Visvader, In situ identification of bipotent stem cells in the mammary gland, Nature, vol.506, pp.322-327, 2014.

K. Roarty, A. N. Shore, C. J. Creighton, and J. M. Rosen, Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium, J Cell Biol, vol.208, pp.351-366, 2015.

P. J. Roberts, J. E. Usary, D. B. Darr, P. M. Dillon, A. D. Pfefferle et al., Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.18, pp.5290-5303, 2012.

A. Roesch, M. Fukunaga-kalabis, E. C. Schmidt, S. E. Zabierowski, P. A. Brafford et al., A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth, Cell, vol.141, pp.583-594, 2010.

L. R. Rohrschneider, J. F. Fuller, I. Wolf, Y. Liu, L. et al., Structure, function, and biology of SHIP proteins, Genes Dev, vol.14, pp.505-520, 2000.

L. R. Rohrschneider, J. M. Custodio, T. A. Anderson, C. P. Miller, and H. Gu, The intron 5/6 promoter region of the ship1 gene regulates expression in stem/progenitor cells of the mouse embryo, Dev. Biol, vol.283, pp.503-521, 2005.

I. B. Roninson, E. V. Broude, C. , and B. D. , If not apoptosis, then what? Treatmentinduced senescence and mitotic catastrophe in tumor cells, Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother, vol.4, pp.303-313, 2001.

J. E. Russo, H. , and J. , Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells, Cancer Res, vol.48, pp.2963-2968, 1988.

K. Rycaj and D. G. Tang, Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations, Cancer Res, vol.75, pp.4003-4011, 2015.

J. Rygaard and C. O. Povlsen, Heterotransplantation of a human malignant tumour to, Nude" mice. Acta Pathol. Microbiol. Scand, vol.77, pp.758-760, 1969.

A. Santoro, T. Vlachou, M. Carminati, P. G. Pelicci, and M. Mapelli, Molecular mechanisms of asymmetric divisions in mammary stem cells, EMBO Rep, vol.17, pp.1700-1720, 2016.

D. Sarrió, S. M. Rodriguez-pinilla, D. Hardisson, A. Cano, G. Moreno-bueno et al., Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype, Cancer Res, vol.68, pp.989-997, 2008.

J. Sarry, K. Murphy, R. Perry, P. V. Sanchez, A. Secreto et al., Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2R?c-deficient mice, J. Clin. Invest, vol.121, pp.384-395, 2011.

A. G. Schepers, H. J. Snippert, D. E. Stange, M. Van-den-born, J. H. Van-es et al., Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas, Science, vol.337, pp.730-735, 2012.

F. Schmitt, S. Ricardo, A. F. Vieira, M. R. Dionísio, and J. Paredes, Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes, Virchows Arch. Int. J. Pathol, vol.460, pp.545-553, 2012.

R. Schofield, The relationship between the spleen colony-forming cell and the haemopoietic stem cell, Blood Cells, vol.4, pp.7-25, 1978.

J. Schrader, T. T. Gordon-walker, R. L. Aucott, M. Van-deemter, A. Quaas et al., Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells, Hepatol. Baltim. Md, vol.53, pp.1192-1205, 2011.

R. M. Seaberg and D. Van-der-kooy, Stem and progenitor cells: the premature desertion of rigorous definitions, Trends Neurosci, vol.26, pp.125-131, 2003.

S. Sengupta, H. , and C. C. , p53: traffic cop at the crossroads of DNA repair and recombination, Nat. Rev. Mol. Cell Biol, vol.6, pp.44-55, 2005.

C. B. Seymour and C. Mothersill, Radiation-induced bystander effects-implications for cancer, Nat. Rev. Cancer, vol.4, pp.158-164, 2004.

M. Shackleton, F. Vaillant, K. J. Simpson, J. Stingl, G. K. Smyth et al., Generation of a functional mammary gland from a single stem cell, Nature, vol.439, pp.84-88, 2006.

M. Shehata, A. Teschendorff, G. Sharp, N. Novcic, I. A. Russell et al., Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland, Breast Cancer Res, vol.14, p.134, 2012.

M. A. Shibata, M. L. Liu, M. C. Knudson, E. Shibata, K. Yoshidome et al., Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage, EMBO J, vol.18, pp.2692-2701, 1999.

M. A. Shibata, K. Yoshidome, E. Shibata, C. L. Jorcyk, and J. E. Green, Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21, Cancer Gene Ther, vol.8, pp.23-35, 2001.

Y. Shimono, J. Mukohyama, S. Nakamura, and H. Minami, MicroRNA Regulation of Human Breast Cancer Stem Cells, J. Clin. Med, vol.5, 2015.

M. Shipitsin, L. L. Campbell, P. Argani, S. Weremowicz, N. Bloushtain-qimron et al., Molecular Definition of Breast Tumor Heterogeneity, Cancer Cell, vol.11, pp.259-273, 2007.

K. Shiraishi, T. Shimura, M. Taga, N. Uematsu, Y. Gondo et al., Persistent induction of somatic reversions of the pink-eyed unstable mutation in F1 mice born to fathers irradiated at the spermatozoa stage, Radiat. Res, vol.157, pp.661-667, 2002.

M. T. Silva, Secondary necrosis: the natural outcome of the complete apoptotic program, FEBS Lett, vol.584, pp.4491-4499, 2010.

P. T. Simpson, J. S. Reis-filho, T. Gale, and S. R. Lakhani, Molecular evolution of breast cancer, J. Pathol, vol.205, pp.248-254, 2005.

A. Singh and J. Settleman, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, vol.29, pp.4741-4751, 2010.

V. K. Singh, J. , and Z. , Targeting synuclein-gamma to counteract drug resistance in cancer, Expert Opin. Ther. Targets, vol.12, pp.59-68, 2008.

A. Singh, H. Wu, P. Zhang, C. Happel, J. Ma et al., Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype, Mol. Cancer Ther, vol.9, pp.2365-2376, 2010.

S. K. Singh, I. D. Clarke, M. Terasaki, V. E. Bonn, C. Hawkins et al., Identification of a Cancer Stem Cell in Human Brain Tumors, Cancer Res, vol.63, pp.5821-5828, 2003.

S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani et al., Identification of human brain tumour initiating cells, Nature, vol.432, pp.396-401, 2004.

V. K. Singh, Y. Zhou, J. A. Marsh, V. N. Uversky, J. D. Forman-kay et al., , 2007.

, Synuclein-? Targeting Peptide Inhibitor that Enhances Sensitivity of Breast Cancer Cells to Antimicrotubule Drugs, Cancer Res, vol.67, pp.626-633

N. E. Sládek, R. Kollander, L. Sreerama, and D. T. Kiang, Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens, Cancer Chemother. Pharmacol, vol.49, pp.309-321, 2002.

K. E. Sleeman, H. Kendrick, A. Ashworth, C. M. Isacke, and M. J. Smalley, CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells, Breast Cancer Res, vol.8, p.7, 2005.

L. M. Sly, M. J. Rauh, J. Kalesnikoff, T. Büchse, K. et al., SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide, Exp. Hematol, vol.31, pp.1170-1181, 2003.

C. M. Smas and H. S. Sul, Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation, Cell, vol.73, pp.725-734, 1993.

W. Song, Y. Hwang, V. M. Youngblood, R. S. Cook, J. M. Balko et al., Targeting EphA2 impairs cell cycle progression and growth of basallike/triple-negative breast cancers, Oncogene, vol.36, pp.5620-5630, 2017.

T. Sørlie, C. M. Perou, R. Tibshirani, T. Aas, S. Geisler et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.10869-10874, 2001.

T. Sørlie, R. Tibshirani, J. Parker, T. Hastie, J. S. Marron et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc. Natl. Acad. Sci, vol.100, pp.8418-8423, 2003.

G. J. Spangrude, S. Heimfeld, and I. L. Weissman, Purification and characterization of mouse hematopoietic stem cells, Science, vol.241, pp.58-62, 1988.

C. G. Specht, C. M. Tigaret, G. F. Rast, A. Thalhammer, Y. Rudhard et al., Subcellular localisation of recombinant alpha-and gamma-synuclein, Mol. Cell. Neurosci, vol.28, pp.326-334, 2005.

K. Srinivasan, P. Strickland, A. Valdes, G. C. Shin, and L. Hinck, Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis, Dev. Cell, vol.4, pp.371-382, 2003.

T. A. Stewart, P. K. Pattengale, and P. Leder, Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes, Cell, vol.38, pp.627-637, 1984.

J. Stingl, C. J. Eaves, U. Kuusk, and J. T. Emerman, Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast, Differentiation, vol.63, pp.201-213, 1998.

J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant et al., Purification and unique properties of mammary epithelial stem cells, Nature, vol.439, pp.993-997, 2006.

A. Strohl, K. Mori, S. Akers, W. Bshara, B. Buttin et al., Synuclein-? (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease, J. Ovarian Res, vol.9, p.75, 2016.

C. H. Stuelten, S. D. Mertins, J. I. Busch, M. Gowens, D. A. Scudiero et al., Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel, Stem Cells Dayt. Ohio, vol.28, pp.649-660, 2010.

G. Sulli, R. Di-micco, and F. Adda-di-fagagna, Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer, Nat. Rev. Cancer, vol.12, pp.709-720, 2012.

Y. Sun, Y. Xu, X. Yang, W. Guo, X. Zhang et al., Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection, Hepatol. Baltim. Md, vol.57, pp.1458-1468, 2013.

I. Surgucheva, B. Mcmahon, and A. Surguchov, gamma-synuclein has a dynamic intracellular localization, Cell Motil. Cytoskeleton, vol.63, pp.447-458, 2006.

I. Surgucheva, V. S. Sharov, and A. Surguchov, ?-Synuclein: Seeding of ?-Synuclein Aggregation and Transmission between Cells, Biochemistry (Mosc.), vol.51, pp.4743-4754, 2012.

I. G. Surgucheva, J. M. Sivak, E. Fini, M. Palazzo, R. E. Surguchov et al., , 2003.

, Effect of ?-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells, Arch. Biochem. Biophys, vol.410, pp.167-176

A. Surguchov, Intracellular Dynamics of Synucleins: "Here, There and Everywhere, Int. Rev. Cell Mol. Biol, vol.320, pp.103-169, 2015.

A. Surguchov, B. Mcmahan, E. Masliah, and I. Surgucheva, Synucleins in ocular tissues, J. Neurosci. Res, vol.65, pp.68-77, 2001.

A. Surguchov, R. E. Palazzo, and I. Surgucheva, Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction, Cell Motil. Cytoskeleton, vol.49, pp.218-228, 2001.

R. Takahashi, H. Miyazaki, F. Takeshita, Y. Yamamoto, K. Minoura et al., Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1, Nat. Commun, vol.6, p.7318, 2015.

N. Takebe, P. J. Harris, R. Q. Warren, and S. P. Ivy, Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways, Nat. Rev. Clin. Oncol, vol.8, pp.97-106, 2011.

H. Takeuchi, Y. Kondo, K. Fujiwara, T. Kanzawa, H. Aoki et al., Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors, Cancer Res, vol.65, pp.3336-3346, 2005.

T. Tanei, K. Morimoto, K. Shimazu, S. J. Kim, Y. Tanji et al., Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.15, pp.4234-4241, 2009.

D. G. Tang, Understanding cancer stem cell heterogeneity and plasticity, Cell Res, vol.22, pp.457-472, 2012.

T. Tanos and C. Brisken, What signals operate in the mammary niche?, Breast Dis, vol.29, pp.69-82, 2008.

R. C. Taylor, S. P. Cullen, M. , and S. J. , Apoptosis: controlled demolition at the cellular level, Nat. Rev. Mol. Cell Biol, vol.9, pp.231-241, 2008.

J. J. Tentler, A. C. Tan, C. D. Weekes, A. Jimeno, S. Leong et al., Patient-derived tumour xenografts as models for oncology drug development, Nat. Rev. Clin. Oncol, vol.9, pp.338-350, 2012.

J. P. Thiery, Epithelial-mesenchymal transitions in development and pathologies, Curr. Opin. Cell Biol, vol.15, pp.740-746, 2003.

J. P. Thiery, H. Acloque, R. Y. Huang, and M. A. Nieto, Epithelial-mesenchymal transitions in development and disease, Cell, vol.139, pp.871-890, 2009.

C. L. Trejo, G. Luna, C. Dravis, B. T. Spike, and G. M. Wahl, Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis, NPJ Breast Cancer, vol.3, p.16, 2017.

M. A. Troester, J. I. Herschkowitz, D. S. Oh, X. He, K. A. Hoadley et al., Gene expression patterns associated with p53 status in breast cancer, BMC Cancer, vol.6, p.276, 2006.

J. H. Tsai, J. L. Donaher, D. A. Murphy, S. Chau, Y. et al., Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis, Cancer Cell, vol.22, pp.725-736, 2012.

Z. Tu, J. M. Ninos, Z. Ma, J. Wang, M. P. Lemos et al., Embryonic and hematopoietic stem cells express a novel SH2containing inositol 5?-phosphatase isoform that partners with the Grb2 adapter protein, Blood, vol.98, pp.2028-2038, 2001.

N. Tung, J. E. Garber, M. R. Hacker, V. Torous, G. J. Freeman et al., Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer, NPJ Breast Cancer, vol.2, p.16002, 2016.